ANDHRA PRADESH BURDEN OF DISEASE AND COST EFFECTIVENESS STUDY

Item

Title
ANDHRA PRADESH BURDEN OF DISEASE
AND COST EFFECTIVENESS STUDY
extracted text
>

ANDHRA PRADESH BURDEN OF DISEASE
AND COST EFFECTIVENESS STUDY
'4

?
5
5
5
5
■b

3

3

3

REPORT

3
3

3
3
3
3
3

3
3
3 ‘

3

3
3

3
3

nI
3

CENTRE FOR SOCIAL SERVICES
ADMINISTRATIVE STAFF COLLEGE OF INDIA
BELLA VISTA HYDERABAD -49

»■

Preliminary results of Disease Burden -NOT FOR QUOTATION 9 October 1995

3

3
5
3
D

3
3
3

Andhra Pradesh Burden of Disease and
Cost Effectiveness Study
I. Introduction

9

There is no doubt that considerable improvement in the health status of the communities

3

did occur during the past few decades. However, much more still remains to be done. While

3

communicable diseases are still common in developing countries, the health systems need to cope

3

up with the ageing population suffering from non communicable degenerative diseases.

3

Emergence of illnesses like AIDS started to throw new challenges upon the systems.

3
3

9
5
9

3
9

Any discussion of the health policy should start with scaling of a problem which aids in

setting health priorities and targeting the health services to the needy and disadvantaged groups of

the society. Most of the assessments of relative importance of different diseases, so far, are based
on how many deaths they cause. This has certain merits as death is an unambiguous event and the

vital registration systems of many countries routinely provide the data required. Even this
approach has lacunae as there are no consistent estimates of adult mortality in many developing

9

countries and the available mortality estimates generally confine to infancy and childhood. There

9

are, however, many non fatal conditions which are responsible for great loss of ’healthy life'.

9

Disability has not been included in estimating the burden as it is considered a problem only in

3

societies that had undergone epidemiological transition.

9

With expanding role of cost-effectiveness in health care planning, the need for more

5

comprehensive measurement of burden of disease has become more urgent. Thus, there is an

9

urgent need for a process through which every disease or health problem would be evaluated in

3

objective fashion so that the programm

k)t be ignored.

3

So far, only one systematic effo

e in Ghana for

9

48 causes. Recently, Christopher Mur

o quantify the

burden of disease which was used by th

)bal Burden of

Disease (GBD)1. This new indicator, th

:s the standard

9
9

9
5
3

3
3

Community Health Cell
Library and Information Centre
1

World Development Report 1993

367, “ Srinivasa Nilaya ”
Jakkasandra 1st Main,
1st Block, Koramangala,
BANGALORE - 560 034.
Phone: 5531518/5525372
e-mail:sochara@ vsnl.com '

Preliminary results of Disease Burden -NOT FOR QUOTATION 9 October 1995

J

expected years of life lost (YLL) on model life table West level 26. The value of time lived at
J

different ages is captured in calculating the DALYs using an exponential function which reflects
the dependence of the young and the elderly on adults. The time lived with disability is made

b

comparable with the time lost due to premature mortality. For this, six classes of severity of

■ disability have been defined and each class was assigned a disability weight between 0 and 1.

o •

Considering the fact that DALY measures the future loss, a social discount rate of three percent

discount has been applied. Details of assumptions used in DALY estimation were summarised in

o
o
b
b
o

Global comparative assessments in the health sector edited by CJL Murray and AD Lopez2.

About 109 categories of diseases (ICD 9), which are responsible for more than 95% of all causes
of death and disability, have been included in this study.

II. Genesis of Andhra Pradesh Burden of disease and Cost
Effectiveness Study:
Subsequent to the Global Burden of. Disease study. National Burden of disease studies

have been planned to provide more insight to the Burden of Disease Approach (BDA). The

o

countries where National burden of disease studies have been initiated include: Mexico, Columbia,

3

South Africa and India. While in other countries these studies have been planned at National level,

O

in India - considering the vast population and reported diversity in disease pattern - it was felt

appropriate to make estimations at state/regional level to begin with. This resulted in the genesis
D

of the Andhra Pradesh Burden of disease and Cost effectiveness of Health Interventions study.
Supported by the World Bank, this study has been undertaken by the Administrative Staff College

of India in technical Collaboration with the Harvard Centre for Population and Development
O
D

O '

studies.

III. Area and People:
The State of Andhra Pradesh, located in the coastal south India extending on to the

deccan plateau, is the fifth largest state in India with a population of 66.3 million3. The state has

o
o

23 districts spread over three distinct geographical regions which include Coastal Andhra with
large coastal plains and fertile deltas, Rayalaseema which is drought prone and interior dry
2

T>
D

Global Comparative Assessments in the Health Sector; Disease burden, expenditures and intervention packages Edited by

CJL Murray and AD Lopez WHO 1994

3

Paper 1 of 1992, Final Population Totals, Census of India 1991; Registrar General & Census Commissioner
2

Preliminary results of Disease Burden -NOT FOR QUOTATION 9 October 1995

J
J

Telangana region. While the coastal plains constitute the most developed part of the state,

Telangana region is more backward in terms of social development. Lack of rains and chronic

hunger is a common feature of Rayalaseema. A large majority of the state's population (73%)
reside in rural areas consisting of about 29,400 villages. About 27% of the state's population
reside in 250 urban towns and cities, a trend more or less common to the rest of the country.
About 80% of the urban population is residing in 66 towns having population more than 50,000

2)

and the three corporations of Hyderabad, Vijayawada and Visakhapatnam

About 15.9% of the population

2)
?



belong to scheduled castes while scheduled tribes

constitute 6.3%. According to 1991 census, the estimated percentage of literates among

population aged seven years and above was 45.11% (Males: 56.2%; Females: 33.7%) compared
to the national average of 52.1%. From a strong agricultural base, the state economy has, over the
years, diversified into industry and science. The National Sample Survey Organisation's estimates

of poverty during 1977-78 (32nd round) and 1983-84 (38th round) indicate that rural poverty in
5

5

the state has declined from 45.45% to 38.67%. The corresponding decline in the urban poverty
during the same period was from 37.02% to 29.4%.

3
5

IV. Objectives:
♦ To estimate the burden caused by common diseases including injuries and

accidents in the State of Andhra Pradesh, India
3



Compare the disease burden of urban and rural areas AP and

D



Study the cost effectiveness of selected health interventions using DALYs

D

as measure of effectiveness

D
2
Z)

5

?
5

3

Preliminary results of Disease Burden -NOT FOR QUOTATION 9 October 1995

5

V. Approach:
The essential approach used in Andhra Pradesh Burden of Disease Study was to gather

relevant information from different sources, discuss with respective experts and to arrive at the

preliminary set of estimates on mortality and disability for each disease. This was followed by a
$

consistency check to validate the estimates made. The disease experts were approached again to

D ■
$

*

give their comments. Thus, the entire exercise - which involved several rounds discussions and
series of workshops with disease experts, researchers, demographers and programme managers went through an extensive consultative process.
For estimation of YLL demographic data on age, sex and cause specific mortality rates are

required while YLD requires epidemiological data on incidence, prevalence, severity and
3

complications or sequelae. The epidemiological estimates are also used to check the consistency

5

of demographic estimates and vice versa. The estimates of burden in APBD study are made for

3

1991 as it happens to be the Census year and hence provides true population distribution.

3

Considering the variations in living conditions and access to health and related services, separate

3

estimates have been made for urban and rural areas. The census definition of urban areas was used

to distinguish from the rural areas.
3
3
3

VI. Demographic Estimates:
A Age specific mortality:

3

A preliminary workshop was conducted to identify the sources of mortality data. Two

3

important sources of population distribution and age specific mortality identified were the 1991

3

Census and Sample Registration Scheme (SRS). In addition, community based studies undertaken

3

from Andhra Pradesh which provided information mortality were listed during the workshop.

7

3
3

3
3
3

The final population totals for AP from 1991 census are not yet available. However, the

primary census abstract provides preliminary data on population by sex below 6 years and above 6

years separately for urban and rural areas. Enquiry with Registrar General's office indicated that it

may take one more year to complete the detailed analysis of 1991 AP Census data. Hence, the
Sample Registration Scheme (SRS) estimates for urban and rural Andhra Pradesh were used to

3
3

3

3

3

4

•0
Preliminary results of Disease Burden -NOT FOR QUOTATION 9 October 1995

b)

develop life tables for males and female?. When the actual population distribution is made
available from 1991 Census data, the SRS estimates will be replaced by them.
B Preliminary disease list preparation:

2)
3

5

3
5

A preliminary list of diseases was prepared after reviewing the available data and
discussing with the local disease experts and demographers. The GBD norm of grouping the
diseases in to three groups on the basis of epidemiological transition was followed. The Group I
included the pre- transition diseases: Communicable, Maternal and Perinatal. Considering the fact

that nutrition deficiency disorders tend to be predominate in pre-transition period, they have been
included in group I. The Group II consisted of non communicable and degenerative disorders
)

while Injuries and accidents were included in Group III. As the cause of death and disease pattern
emerged this preliminary disease list was modified to ensure that it captures all the major causes

I

$

of mortality and morbidity in AP.
C Cause of Death determination:
I

Like many developing countries the Vital Registration System in India is p„Or both in

i

terms of coverage as well as content. The usual option in such situation is either to use cause of
death models or to estimate the cause of death pattern using epidemiological approach. The
model based estimates may not capture the true cause of death pattern in developing countries as
they are mostly based on past mortality patterns observed in developed countries. They are also

influenced by changes in ICD revisions and diagnostic practices.

In case of epidemiological

estimates, adequate data may not available for all diseases to make estimations. Another option is
to make the cause of death estimates using data from sample registration schemes or disease

surveillance systems. In India two schemes provide information on cause of death pattern. Survey

of Cause of Death (SCD) provides cause of death information for broad cause groups in nira!
areas usmg Verbal Autopsy techniques while Medical Certification Cause of Death (MCCD)

provrdes physician certified cause of death information from selected hospitals. This data is
available in three digit ICD 9 coding.

I
!

I

Annexure I
5

Ik

Preliminary results of Disease Burden -NOT FOR QUOTATION 9 October 1995

i.

Cause of death estimation for rural AP:

The SCD Scheme- started as Model Registration Scheme in 1960s by the Registrar

o

General, India - provides cause of death information for rural India using " lay reporting " method.

xO

In each state sampling units, covering 3-5 thousand rural residents each, are selected using

xO

standard guidelines to ensure representativeness. The state of Andhra Pradesh at present has 150

c ■

sampling units covering a population of 0.675 million which constitutes about 1% of the total

o

population.

O ■

The field work is restricted to the sample village and carried out by para medical worker

0

(called Field Agent) of the selected Primary Health Centre trained in the verbal autopsy

0

techniques. A set of guidelines for classification of diseases by a non-medical list of causes of

0

0
0
0

0
0
0

0
0
0
0

death prepared by the office of the Registrar General of India is provided. The cause of death
determination process involves isolation of major cause groups by way of elimination and final
identification of specific cause in stages. The medical officer of the PHC scrutinises the deaths

recorded by the field agent every month and investigates independently at least two deaths or 10%
of deaths recorded to validate the information collected by the field agent.
Constraints of SCD data:

A. Methodological:

The verbal autopsy technique is essentially based on two assumptions:
♦ Each disease will have unique set of symptoms at the time of death

♦ The attendants can provide detailed description of events that led to death

0

Both these assumptions may not always hold good. There is often overlap of symptoms or

0

the attendants may not be in a position to provide the detailed description of symptoms at the time

0

of death. Another important determinant of quality of verbal autopsy technique is the skill of the

0 '

interviewer to extract the required information from the attendants.

0

B. Large number of Unclassified deaths :

0

Under SCD the cause of death determination is done in a phased manner. Each death is

0

initially classified under 10 major groups and then specific cause is determined. In case of deaths

0

with inadequate information, the general tendency is to include the death in one of the major

5
)

groups without further probing. Since, BDA requires specific cause of death information, there

was no choice but to include deaths under the categoiy of "not classified".

)

)

)
)

6

Preliminary results of Disease Burden -NOT FOR QUOTATION 9 October 1995

1

A preliminary analysis of SCD data from the state of AP for a period of six years
(1988-93) had shown that out of a total 10,770 deaths (Males: 5979; Females: 4791) reported
during this period, more than a third ( 37.5%) come under the 'not classifiable' category. Two

thirds of the deaths included under 'not classifiable' category and 25% of the total deaths were
due to senility4.
C. Cause of death information restricted to few diseases:

Like any Verbal Autopsy technique the SCD provides cause of death information only for

few diseases. Even among them some of the causes which are described more on the basis of
symptoms are difficult to classify. Conditions such as jaundice, convulsions, paralysis, congestive

heart failure etc., fall under this category. Similarly all cancers were included in a single group.
Unless some additional information is provided it is not possible to classify these deaths. Though

SCD protocol insists on recording such information by the field agent, it is often not enforced
which makes it difficult to classify these deaths.
5

Expert opinion and field enquiry to Improve the quality of SCD data:

'

With all these constraints SCD still happens to be the single largest source of cause of
1
f

death information from the rural community. In the APBD study an attempt was made to explore

the scope to further improve the quality of SCD data. This is done in four stages.
♦ Initial review of cause of death description given for the unclassified deaths

by medical experts

♦ Field enquiry of 301 deaths included in not classifiable category during
1992-93 (all the deaths with records available covered)



Separate survey of 139 deaths classified under 'senility’ during 1994 by

trained experienced investigators to get more detailed description on events

that led to death and symptoms at the time of death.


Review of the field data by committee of experts (Physician, Paediatrician
and Public Health Specialist)

Out of a total 440 deaths subjected to expert opinion and field enquiry 436 (99%) could
be classified. Based on this feedback few more categories of diseases were to the SCD list. For
example, enquiry revealed that 'electric shock' is an important cause of death in rural males. Using

7

Preliminary results of Disease Burden -NOT FOR QUOTATION 9 October 1995

this data an algorithm was developed to classify the deaths included in not classifiable category of

SCD deaths5.
ii. Estimation Cause of death for Urban AP:

Preliminary analysis of vital registration data from one circle in Hyderabad City indicated

that content is poor as cardiorespiratory failure was reported to be the cause of death in as many
as 40% of the deaths registered.

o ■

Review of MCCD data had shown that only one third of the total urban deaths are being
covered under this scheme in AP. However, in the neighbouring state of Maharashtra more than
80% of the urban deaths are medically certified. Considering the proximity of the states and
genetic similarity of population, we have assumed that the cause of death pattern in urban

Maharashtra closely resembles that of urban AP. MCCD data from Maharashtra state covering a




period of five years (1986 -90) was obtained and aggregate cause specific proportionate mortality

rates were calculated for APBD age groups separately for both sexes. These rates were applied to
the estimated deaths for Urban AP in each age and sex group to arrive at the first estimates of

cause specific deaths in urban AP.

3

VII.Final APBD disease list and cause of death estimates:

3

3

After going through the list of major unclassified deaths in rural and urban AP, the disease

3

list was finalised6. Where ever felt necessary, new disease was added and some diseases were


3

excluded. For example, Japanese encephalitis was added in communicable diseases while

Leishmaeniasis was excluded. Similarly electric shock and bites by venomous snakes were added

3

in injuries and accidents. Since available cause of death data can not distinguish between acute

5
3
3

□.

and persistent diarrhoea, we have included all the diarrhoea's in one group. This decision was also
influenced by the fact that interventions for diarrhoea - irrespective of the clinical forms - are
similar.

'3

In both urban and rural areas the estimated deaths by cause were matched with the APBD

3

list of diseases. Appropriate algorithm was developed separately for rural and urban areas to

3

distribute all the remaining deaths which are responsible for more than 0.1% of total deaths7.

3

3

3
3

3

3

s

Annexure III

Annexure II
7

Annexure IV

8

Preliminary results of Disease Burden -NOT FOR QUOTATION 9 October 1995

£
£

£
0

VIII. Epidemiological Estimates of mortality and disability :
Epidemiological estimates on disability and mortality were made for each of the disease

0

included in the list. Considering the fact that SCD data can provide only broad leads the data was

0

further validated for each disease using epidemiological approach. Similarly, the estimates of

0

cause of death in urban areas made on the basis of Maharashtra MCCD data were also validated.

0

A Disease experts and Literature review:

3

For each of the disease included in the list experts have been identified through references

0

and contacting National laboratories. The first round of communication was sent to them which



described the methodology with a request to provide first set of estimates on incidence,

prevalence, case fatality and remission rates for their respective diseases. The experts were also
3

requested to quote the sources on which their estimates are based and give their opinion on
quality of available data. This was followed by personal visit of project team members to different

parts of the state and some of the National laboratories to clarify any doubts and to get more
5

information on available epidemiological data in the state/country.

3

Meanwhile, a detailed literature search was undertaken to compile the epidemiological

?

studies on each disease giving first preference to community based studies undertaken in AP.

5

Information was also obtained from Post graduate dissertations and small scale surveys

)

undertaken in different parts of the State through departments of community medicine. If there

5

are no good community based studies available from the State, studies undertaken in neighbouring

)

States or at National level were considered. For example, in case of cancers, the reported

!

*i

)

incidence from Madras cancer registry was used for epidemiological estimates. If adequate

)

information is not available even at National level, data from comparable studies in neighbouring

)

)

countries was considered. For example, in case of Chlamydia we could not get any community

based studies from India and all the studies reviewed were hospital based.

Hence, reported

prevalence figures from Asian population in Singapore were used to arrive at the preliminary
estimates. If no data is available from neighbouring countries, the GBD approach of using data
from other comparable country was used. Use of hospital based studies was essentially restricted
I

for estimation of case fatality and remission rates.

9

i

Preliminary results of Disease Burden -NOT FOR QUOTATION 9 October 1995

For all diseases with National programmes surveillance data was obtained from the

V)

concerned programme manager. This information was particularly useful in case of vaccine
preventable diseases as immunisation coverage significantly alters the disease burden. The details

V)

O
O

of quality of reviewed studies are presented in Table. As it is evident from the table that better
epidemiological data is available for Group I diseases8. The estimates for some of the Group n
k

o

diseases hence were based on small scale studies and studies published from other countries. To

0 -

make the approach used more explicit

o
o

o

include Tuberculosis with good epidemiological data and Non Insulin Dependent Diabetes

two examples of epidemiological estimations, which

Mellitus with poor epidemiological data, are presented in Annexure’.

After first round of literature review, expert comments and programme data analysis a

workshop was held. The participants included core expert, local disease experts, programme
managers and public health specialists. The first set of epidemiological estimates of all chronic



diseases made were subjected to consistency using the Harvard disease model (DISMOD) which

uses the known relationships between incidence, prevalence, case fatality and remission10 In case



of acute diseases responsible for large number of deaths, consistency of epidemiological estimates

J

were checked with the cause of death models.

5

B Final estimates of cause of death:
A combination of sources were used to estimate the cause of death pattern. Firstly all
estimations of injury and accidents based on survey reports for rural and urban areas were taken

as such. Then the proportionate distribution of deaths in group I and group n from
epidemiological approach was compared with that of survey data. In urban areas only marginal '
9

differences were noticed between the two sets of estimates. Hence, the survey distribution for

9 .

group I and H was taken as such while the distribution of deaths within each group was based on

9

epidemiological estimations.

9

9



I

In case of rural areas, however, some inconstancies were noticed. As mentioned earlier the

SCD data provides information only for broad cause groups and some of the cause of death
descriptions such as convulsions, congestive heart failure, jaundice etc. essentially describe

)
)

symptoms which may occur due to many diseases. The major discrepancy was noticed in case of
Annexure V
Annexure VII



10

CJL Murray & A D Lopez; Quantifying disability: data methods and results; Bull of WHO 1994, 72 (3): 431-494

10
i

I
I

Preliminary results of Disease Burden -NOT FOR QUOTATION 9 October 1995

Diarrhoea and ARI where the SCD data tended to underestimate the deaths particularly in 0-4 yrs.

The reported validity of verbal autopsy for childhood deaths varied considerably between studies.

Studies in Kenya have shown that the sensitivity of verbal autopsy techniques was low for ARI11
The deaths estimated from epidemiological approach were also compared with model based
■)

estimates using Preston's cause of death models of countries with comparable mortality pattern.

Preston12 made an estimate of Cause Specific Mortality Rate for 12 major causes of death using

data from 48 Nations with a range of life expectancies from 27 to 77 yr. From this data

5

proportionate mortality rates due to diarrhoea for three countries which had general mortality

? •

rates comparable to India were calculated. All these estimates suggest a proportionate mortality

due to diarrhoea was between 23-29% in the 0-4 years which is consistent with the
)

)

epidemiological estimates. Studies on diarrhoea mortality report

aa cause
cause specific mortality

between 0.8 to 1.5/1000 among children in 5-14 and 0.4 to 2.5 per 1000 per year in case of
. Hence, for diarrhoea and ARI we have based the estimates more epidemiological

adults

approach.
The Maternal deaths were taken as reported from the survey data far both urban and rural

r

areas as the expert felt that MMR estimates seemed to be quite plausible. However, in case of

Perinatal Mortality the SCD data seemed to be an over estimate. An estimation of neonatal
mortality was made on the basis of observed relationship between the neonatal and post-neonatal

mortality . The estimates suggested that perinatal mortality estimates based on survey data were
higher in rural areas while in urban areas they matched fairly well. Considering these constraints
we have essentially used the epidemiological approach to estimate the cause of death pattern in

rural areas while estimates based SCD data were used as such for injuries & accidents, Maternal

it

12
13

Snow RW et al Childhood deaths in Africa: uses and limitations of verbal autopsies. Lancet 1992 340:351-55

Samuel H Preston; Causes of Death, Life tables for National Populations; Seminar Press 1972 ISBN 0-12-895550-3
El Alamy MA et al. The incidence of diarrhoeal disease in a defined population of rural Egypt. American Journal of Tropical

Medicine and Hygiene, 35:1006-1012 1986
Nazir HZ M et al., The incidence of diarrhoeal diseases and diarrhoeal diseases related mortality in rural swampy low-land area

of south Sumatra, Indonesia. J of Tropical Paediatrics, 31:268-272

Shaikh K et al. Pattern of diarrhoeal deaths during 1966-1987 in

a demographic surveillance area in rural Bangladesh. J of

Diarrhoeal Diseases Research 8: 147-154 (1990)

CJL Murray & Jose Luis Bobadilla; Epidemiological Transitions in the Formerly Socialist Economies: Divergent Patterns of
Mortality and Causes of Death; Health Transition Working Paper Series No.94.07 1994

11

Preliminary results of Disease Burden -NOT FOR QUOTATION 9 October 1995

'O

Mortality and for checking the total estimated deaths under broad groups such as Gastrointestinal,
Chronic respiratory disorders. Neuropsychiatric diseases etc.

IX.Results
A Probability of dying:

The first round of estimates suggest that probability of dying in 0-14 years in AP is less

O-

compared to all India average for both sexes (Males: 13% Vs 15%; Females: 11% Vs 16%) Both
urban and rural AP fared better than all India average. This trend, however, altered for the later
age groups. While marginal differences were noticed among males in 15-59 years (Males: AP:

28%, India 27% ), no difference was noticed among females. In 60-69 years age group the

probability of dying in AP was higher than that of all India averages for both sexes (Males: AP:
40%, India: 32%; Females: AP: 29%, India 26%).

is

s
s

Between the urban and rural areas, probabilities of dying were lower for all age groups in
urban areas. Lower child mortality and higher adult mortality in AP compared to India suggest
that health interventions targeted at children are more effective in AP. This also indicates that the

demographic transition process is more advanced in AP compared to the National average
B Cause of death
s ’
)

)

A. Cause of death pattern :
The estimated cause of death patient for all age groups in urban and rural AP is presented
m the figure L Whiie Group ! diseases predominated in rural areas, Group I! diseases were

responsible for hrgher mortality in urban areas. About 11% of deaths in rural and S% in urban

areas were due to injuries and accidents. In both rural and urban areas unintentional injuries

constituted the majority of Group in deaths. The proportion of deaths constituted by intentional
mjunes was hrgher m mral areas compared to urban areas (28% Vs 7%). Eighty seven percent of

estimated intentional deaths in rural areas were self Micted compared to 37% in urban areas

indicating a higher suicide rate among rural residents.

12

Preliminary results of Disease Burden -NOT FOR QUOTATION 9 October 1995

Fig 1

£ .
1) .

CAUSE OF DEATH PATTERN IN AP

52.0%

42.4%

2)

10.8%

RURAL AP
SCD+EPD

0

8.4%

49.3%

37.2%

URBAN AP
ICCD+EPD

■ GROUP I £3 GROUP II ■ GROUP III

3

3

7
7

7
)

When the cause of death pattern in AP for all ages and both sexes was compared with that
of India the proportion of deaths due to Group I (50.1% Vs 43.3%) and Group in (10.3% Vs

6.5%) diseases was higher in AP. Considering the lower probabilities of dying in 0-4 years in AP,

where Group I diseases predominate, this trend is surprising.
B. Cause of death pattern by sex

Similar trend was obseiwed when cause of death pattern was compared between the sexes.
While Group I deaths predominated among both sexes in rural areas, deaths due to Group Q

i

I

were higher in urban areas. In both areas proportion of deaths due to Group II was higher among
females. This difference was more marked in case of urban area. This is quite plausible
considering the fact that females are considered to be genetically stronger than males and hence

less vulnerable to infectious diseases. Proportionate mortality due to Group HI deaths between
the two sexes was more or less similar in rural areas while in urban areas males tended to have

marginally higher mortality due to Injuries and accidents compared to females.
C. Cause of death pattern by age:

0-4 Years:

About 90% of the estimated deaths in this age group were due to Group 1 diseases. The

proportion of deaths due to Group I diseases was higher in rural areas compared to urban areas
(91 /o Vs 85/o). The leading causes of death included Perinatal conditions (M: 27.4%, F: 26.6%)
ARI (M:22.2%, F: 23.9%), Diarrhoea (M: 19.1%, F: 18.9%) and Measles (M: 6.6%, F: 7.5%) in

rural areas.

Even in urban areas, excepting Measles, the same causes were responsible for

H

13

I

Preliminary results of Disease Burden -NOT FOR QUOTATION 9 October 1995

maximum number of deaths. The higher proportion of Group II deaths in urban areas was mainly

due to congenital anomalies. While proportion of Group III deaths are comparable between rural
■o

and urban areas among male children, in case of female children however, the corresponding

:o

proportion was higher among rural residents compared to their urban counterparts. Most common
cause of the Group III deaths among rural girl children was "fall". It is difficult to say to what

O'

extent this is due to gender discrimination and female infanticide. This aspect, however, requires

o
o
o
o

the estimated deaths in urban areas were due to Group II causes, only about a tenth of the total

0

deaths were due to non communicable diseases in rural areas. The leading causes of Group I



further in-depth studies.
5-15 Years:
In this age group also the Group I causes of death predominated. While about a quarter of

deaths included ARI, Anaemia, Diarrhoea and Measles in rural areas and ARI in urban areas.
The proportion of deaths due to Injuries and accidents in this age group was much higher in rural

0

areas compared to urban areas (Males: 38% Vs 17%; Females: 24% Vs 17%). The leading cause
of accidents in rural areas was "Drowning" while in urban areas it was " Motor Vehicle
Accidents".
15-45 Years:

5

While the Group I diseases still predominated the cause of death at state level, the

3

difference between the proportionate mortality due to Group I and Group II diseases was less

5

marked in urban areas compared to rural areas. Tuberculosis was the leading cause of death

3

among Group I diseases among males and females in both rural and urban areas. However, in

9

rural areas deaths due to maternal conditions contributed equal number of deaths. Marked

9

difference in proportionate mortality due to maternal conditions was noticed between rural and

9 '

urban areas (32.3 /'o Vs

9

digestive disorders, cardiovascular diseases and cancers in both urban and rural areas while the

3

leading Group II causes among females included cancers and cardiovascular diseases. The most

3

3
)

6.5%), The leading causes of Group II deaths among males included

common cancers among males were that of Mouth & oropharynx, Oesophagus, Stomach and
Lymphomas & Leukaemias. In females Cancers of Cervix, Breast and Oesophagus were more

common.

)

14

!

5
Preliminary results of Disease Burden -NOT FOR QUOTATION 9 October 1995

5
Deaths due to injuries and accidents constituted a major cause of death in this age group.

In rural areas higher proportion of deaths were caused by unintentional injuries among males

compared to intentional injuries (18% Vs 12.7%). The leading cause of unintentional injury
among males in rural areas was "Motor Vehicle Accidents" while "Self Inflicted" predominated
2?

among intentional injuries. In case of rural females the proportionate mortality due to intentional

J

injuries was higher than that of unintentional (13.2% Vs 11.7%). The leading causes of death

were Fires and Self Inflicted respectively among non intentional and intentional injuries. In urban
2)

areas the unintentional injuries predominated in both sexes (Males: 23.5% Vs 2.4%, Females:

3

31.6% Vs 1.8%). Similar to rural areas, the Motor Vehicle Accident was the leading cause of

death among unintentional injuries in urban males.
2)

J

In case of females, however, Fires were

reported to be the leading cause. Thus Fires emerge as a leading cause of Group III death among

females irrespective of the place of residence. Some of the deaths reported under unintentional

Fires could be due to suicide or even homicide. It is, however, difficult obtain reliable information
5
5
3

on exact cause of death in such circumstances.

45- 59 Years:
In both rural and urban areas the Group II deaths predominated in this age group. It is

however, interesting to notice that still a third of total deaths from rural areas were estimated to
be due to Group I conditions both among males and females while in urban areas about a quarter
>

of deaths in this age group were estimated to be due to Group I conditions. The most common

Group I cause of death was Tuberculosis among males and females irrespective of their place of
>

residence. Among Group II conditions EHD, Cancers and Cirrhosis were estimated to be the
leading causes among males in both rural and urban areas. Among females Cancers, Cerebro
Vascular Accident and HD were the leading causes of death. Group III deaths were more or less

)

uniformly distributed. In rural females deaths reported under the category of "Self Inflected"
tended to be higher.
60 + years:

>

>

Majority of the deaths in this age group were due to Group II conditions. The proportion
of Group I deaths among rural males was higher than urban males (25% Vs 22%) while no such

>

difference was observed among females.

Tuberculosis, Respiratory Infections and Diarrhoea

1

were the leading Group I cause of deaths in this age group. Among Group II diseases, Ishaemic
15

Preliminary results of Disease Burden -NOT FOR QUOTATION 9 October 1995

Heart Disease, Cerebro Vascular Accidents, Cancers, COPD and Cirrhosis Liver were the leading
causes of death among males. More or less similar trends were noticed among females except for
lower estimates of deaths due to Cirrhosis. In urban males also deaths due to cirrhosis were less.
■o

C Disability Adjusted Life Years Lost in AP:
i.

Total DALYs lost:

The preliminary estimates indicate that 17,657,518 total DALYs were lost in Andhra
Pradesh during the year 1991l7. Out of the total DALYs lost 14,037,909 (79.5%) were estimated

o
o
o
o
o
o

to be from rural areas and the rest (20.5%) were contributed by residents of urban areas.

Considering the fact that rural population constituted 73% of the total State's population, it is
evident that disease burden is higher among rural residents. About 52% of the total DALYs lost

were contributed by males and the rest by females.
ii.

DALYs lost per 1000 population:

Fig 2
DISTRIBUTION OF DALYs IN INDIA & AP

3

5

J3445

INDIA

3

267.1

AP ALL

3

H i

AP RURAL

3
3

292.5

197.4

AP URBAN

5
LAC

?

0

5

■ GROUP I

)

100 200 300 400 500

GROUP II ■ GROUP III

)

)

When the APBD preliminary results were compared with that of GBD it is evident that


DALYs lost per 1000 persons in the State of AP were less than all India estimates (267 Vs. 345)
as shown in Fig 2. It is also evident that there is significant difference in the disease burden in

Urban and Rural areas (197 Vs. 293). Since GBD estimates are made at country level for all the
17

Annexure VI
16

I
-;i
■J

Preliminary results of Disease Burden -NOT FOR QUOTATION 9 October 1995

o
6
o
o
o
o


States without distinguishing between urban and rural areas, these trends seem quite plausible.

Also, the fact that SCD cause of death pattern - which is based on rural deaths - was used for
Group I, II and III distribution in GBD estimates which could have influenced the estimates more

in favour of rural areas.. DALYs estimated to be lost/1000 population in Urban AP (197) indicates

that disease burden among residents of Urban AP is marginally lesser than the GBD estimates for
Latin American Crescent (231).

3

iii. DALYs lost due to YLL:

a
3

Fig 3

3

3
3
3

3
3

3

3

DISTRIBUTION OF YLL & YLD DALYS
■ YLL
□ YLD

APALL
RURAL ALL
URBAN ALL

AP MALE
RURAL MALE
URBAN MALE
AP FEMALE
RURAL FEMALE
URBAN FEMALE
0

3

40
20

80
60

120
100

3

3
3

At the aggregate level DALYs lost due to YLL were responsible for two thirds (68.2%)
of total DALYs lost. In both rural and urban areas YLL contributed a majority of total DALYs

lost. In the GBD study also similar trends were observed in most of the developing countries. The

proportion of DALYs lost due to YLL was higher in rural AP compared to urban AP (69.3% Vs
)

63.6%). Between the sexes, males lost higher DALYs due to YLL in both rural and urban areas

I

(Rural:MaIes:72%, Females:66.5%; Urban: Males:67.3%, Females:59.18%).

17

Preliminary results of Disease Burden -NOT FOR QUOTATION 9 October 1995

iv. DALYs lost by major Groups:

Fig 4

O

aSTRIBUTlON OF CXLYS BY U*JOR GROUPS: A P
CRCXJPI

o.
o

GROUP H

CROUP I

3

More than a half of the total DALYs lost (54%) were due to Group I disorders. Since
3

3

YLL happens to be the major contributor of the DALYs lost, this trend is not surprising. About

30% and 16% of the total DALYs lost were due to non communicable diseases, injuries and
accidents respectively. Between the areas, the burden caused by Group I and Group III was more

■3

'3

in rural areas compared to Urban areas. In urban areas also burden caused by Group I diseases is

responsible for maximum loss of DALYs. However, the burden caused by Group II disorders was
relatively higher in urban areas indicating that the urban residents are in a more advanced phase of
epidemiological transition (Fig. 5).

Fig 5

3

3

DISTRIBUTION OF DALYS BY SEX AND AREA
53.9%

49.4%

3

3

28.9%

12.1%

17.2%
36.5%

RURAL MALE

3 .
3

3
3

URBAN MALE

58.2%

51.8%

18.4%

12.5%

27.4%

35.9%

RURAL FEMALE

■ GROUP I

URBAN FEMALE

GROUP II ■ GROUP III

3
3
9

7

18

Preliminary results of Disease Burden -NOT FOR QUOTATION 9 October 1995

X. Leading causes of DALY loss
As shown in the above figures the major causes of DALY loss in Group I diseases include
Perinatal, ARI and diarrhoeal disorders. Burden due to TB was much higher in case of males.

Females residing in rural areas lost nearly double the DALYs /1000 population due to Maternal

0

conditions compared to their urban counterparts. DALYs lost due to Measles, Tetanus were

lower in urban areas which could be attributed to better immunisation coverage and cleaner
delivery practices. DALYs lost due to diarrhoea in urban areas were nearly half that of rural areas

indicating better access to safe water and sanitation.
Fig 6

Group I diseases AP
3.65

13 03

3J7

18 68

12J1

1836

9.84
10.65

17.98

1932

338

3.46

J

21S2
5.15

Males

3.98

Females

r~

Diarrhoeal
Diseases ■ Tetanus ■ Measles ■ Meningitis
Maternal —
■ PerinatalI
E3 Anemia S PEM
■ Others

a tb

ARI

Fig 7
J

Leading causes for DALYs lost in Group II

J

Group II Diseases : AP

5
17.9%

J

17.I*A

12.7%

3

11.9%

10.7%
14.0%

4.4%

14.5%

5.4%
4.4%

J

2.4%
3.1%

1.5%

14.3%

5.5%
5.4%

3.0%
8.9%

7
7

Males
■ Malgnant
83 Chronc Raaorutcry

Females

C
___
Of
Hojro-PiyOMatic
D ■ Cataract n»fal*d bil ■ IHD
■ CVD
Q PEMC
■ CJnho** w
of. ha .v
lv

S2 Nachnfia
0 CoAgarvtW ahnermaU H Oral Kaalth B Otbar*

7
7
*)

19

v9

^9

Preliminary results of Disease Burden -NOT FOR QUOTATION 9 October 1995

o
o
o
o
o
o
o
o

Figure 8
Leading causes of burden in Group III
25.5%

38.1%

14.4%

8.6%

5.0%

*
8.9%

19.5%
14.3%

Males

3

13.6%

5-2\o%

13.7%

12.4%

3.3%

Females

■ MVA
Falta
■ Fires
vwih,
■ ^
Drowning
■ Venamous Animato API
El Electric Shock B Self -Inflicted ■ Homicide & Violence S Others

3

3>
Among the Group II disorders the leading causes of burden include Ischaemic Heart
disease, Cancers, Cerebro-vascular accidents, Congenital disorders and Cirrhosis in both rural and
5

urban areas. Falls and Fires were the most common causes of burden among Group III disorder's

3

in case of females residing in rural and urban areas respectively. Self inflicted injuries were more

3

commonly reported from rural areas among both sexes.

XI.Discussion:
9
9

The preliminary results of the APBD study indicate that the epidemiological transition

9

process in AP is at a more advanced stage compared to that of India. Like many other developing

9

countries the DALYs lost due to premature mortality contributed more to the disease burden. The
fact that urban residents had lesser burden of disease compared to their rural counter parts is not

r .

surprising considering the better access to health care and infrastructural services such as safe
water supply. Burden caused by pre-transition disorders such as infectious diseases, maternal and

/

perinatal conditions and

nutritional deficiencies contributed to more than a half of the total

DALYs lost. This calls for an exhaustive review and total revamping of the existing intervention

programmes. The fact that nearly 16% of the DALYs lost were due to injuries and accidents

20



3

5

Preliminary results of Disease Burden -NOT FOR QUOTATION 9 October 1995

J

D

needs special attention by the policy makers particularly the reported high mortality rates due to
falls, fires and suicides.

The APBD study summarises the experience of estimating the disease burden in a

3

developing country with several constraints of data. The basic objective of the study is to estimate
the burden making use of the 'available data' rather than waiting for the "best data". The

consultative process which involved Disease experts. Researchers, Public health specialists and

Health programme managers .and the consistency checks enforced at different levels helped to
3

make the best plausible estimates. The study team, however, would like to continue the dialogue

with the Reserachers/Disease experts. Based on their feed back on the preliminary estimates next

5

revision will be made.

5

5


J

5
5

5

21

3
3
3

Preliminary results of Disease Burden -NOT FOR QUOTATION 9 October 1995

0

Annexure I

3

0

Life Table for AP Rural Male
x

n

Mx

ax

qx

Px

lx

dx

Lx

Tx

ex

3
3 .

0

1

0.08

0.3

0.07

0.93

100000

7396.17

94822.68

5725792.3

57.26

1

4

0.01

0.4

0.03

0.97

92603.83

2972.01

363282.49

5630969.62

60.81

5

5

0

0.5

0.01

0.99

89631.82

803.07

446151.4

5267687.13

58.77

0

10

5

0

0.5

0.01

0.99

88828.74

795.88

442154.03

4821535.73

54.28

15

5

0

0.5

0.01

0.99

88032.87

1223.89

437104.6

4379381.7

49.75

20

5

0

0.5

0.02

0.98

86808.97

1718.99

429747.4

3942277.09

45.41

25

5

0

0.5

0.02

0.98

85089.98

1392.5

421968.68

3512529.7

41.28

30

5

0

0.5

0.02

0.98

83697.49 • 1903.16

413729.55

3090561.02

36.93

35

5

0.01

0.5

0.03

0.97

81794.33

2099.36

403723.26

2676831.47

32.73

40

5

0

0.5

0.02

0.98

79694.97

1928.9

393652.61

2273108.21

28.52

45

5

0.01

0.5

0.05

0.95

77766.07

4015.2

378792.37

1879455.6

24.17

0.07

0.93

73750.87

5022.4

356198.38

1500663.23

20.35

3 •
3
3
3
3
3
3
3

50

5

0.01

0.5

55

5

0.02

0.5

0.1

0.9

68728.48

6918.54

326346.04

1144464.85

16.65

60

5

0.05

0.5

0.21

0.79

61809.94

13047.54 276430.86

818118.81

13.24

65

5

0.06

0.5

0.27

0.73

48762.4

13142.54 210955.67

541687.95

11.11

70

5

0.11

(3NA

1

-• 0

35619.87

35619.87 330732.27

330732.27

9.29

x

n

Mx

ax

qx

Px

lx

dx

Lx

Tx

ex

o

i

0.07

0.3

0.06

0.94

100000

6217.12

95648.02

6147638.88

61.48

Life Table for AP Urban Male

0
3

3
3
3

3

i

4

0.01

0.4

0.03

0.97

93782.88

2369.25

369445.31

6051990.86

64.53

5

5

0

0.5

0

1

91413.63

455.93

455928.31

5682545.55

62.16

0

1

90957.7

363.1

453880.73

5226617.24

57.46

52.68

10

5

0

0.5

15

5

0

0.5

0

1

90594.59

451.84

451843.36

4772736.52

20

•5

0

0.5

0.01

0.99

90142.75

1119.79

447914.29

4320893.16

47.93

25

5

0

0.5

0.01

0.99

89022.96

753.49

443231.09

3872978.87

43.51

965.65

438933.22

3429747.78

38.86

3

30

5

0

0.5

0.01

0.99

88269.47

3

35

5

0

0.5

0.01

0.99

87303.82

1256.79

433377.11

2990814.56

34.26

40

5

0.01

0.5

0.04

0.96

86047.02

3374.39

421799.14

2557437.45

29.72

3

45

5

0.01

0.5

0.03

0.97

82672.63

2683.91

406653.38

2135638.31

25.83

3 .

50

5

0.02

0.5

0.07

0.93

79988.72

5819.46

385394.94

1728984.93

21.62

55

5

0.02

0.5

0.11

0.89

74169.26

8429.52

349772.49

1343589.99

18.12

3

60

5

0.03

0.5

0.15

0.85

65739.74

10104.47 303437.52

993817.51

15.12

3 '

65

5

0.05

0.5

0.24

0.76

55635.27

245251.35

690379.99

12.41

70

5

0.1

($NA

1

0

42465.27

42465.27 445128.63

445128.63

10.48

3

3
3
3
3

3

3
3

22

13170

Preliminary results of Disease Burden -NOT FOR QUOTATION 9 October 1995

Life Table for AP Rural Female
I-X

Tx

ex

7125.89

95011.88

6072352.14

60.72

92874.11

2194.09

366230.63

5977340,27

64.36

90680.02

902.29

451144.39

5611109.64

61.88

5159965.25

57.47

ax

qx

Px

lx

dx

0.07

0.93

100000

x

n

Mx

0

1

0.08

0.3

0.02

0.98

0.01

0.99

I

4

0.01

0.4

5

5

0

0.5

10

5

0

0.5

0.01

0.99

89777.73

626.25

447323.03

15

5

0

0.5

0.01

0.99

89151.48

1327.32

442439.11

4712642.22

52.86

20

5

0

0.5

0.02

0.98

87824.16

1394.03

435635.73

4270203.11

48.62

25

5

0

0.5

0.02

0.98

86430.13

1541.87

428295.98

3834567.38

44.37

30

5

0

0.5

0.01

0.99

84888.26

928.66

422119.66

3406271.4

40.13

35

5

0.01

0.5

0.03

0.97

83959.6

2400.03

413797.93

2984151.74

35.54

40

5

0

0.5

0.02

0.98

81559.57

1814.68

403261.17

2570353.81

31.52

45

5

0.01

0.5

0.03

0.97

79744.9

2240.8

393122.49

2167092.64

27.18

50

5

0.01

0.5

0.05

0.95

77504.1

4111.92

377240.68

1773970.15

22.89

5543.7

353101.64

1396729.46

19.03

55

5

0.02

0.5

0.08

0.92

73392.18

60

5

0.02

0.5

0.11

0.89

67848.48

7711.15

319964.53

1043627.83

1538

65

5

0.04

0.5

0.2

0.8

60137.33

1 1845.85 271072.05

723663.29

12.03

70

5

0.11

(fl|NA

1

0

48291.49

48291.49 452591.24

452591.24

9.37

x

n

Mx

ax

qx

Px

Lx

Tx

ex

0

1

0.05

0.3

0.05

0.95

100000

4550.3

96814.79

6707644.78

67.08

1

4

0

0.4

0.01

0.99

95449.7

1030.25

379326.22

6610829.99

69.26

5

5

0

0.5

0

1

94419.45

282.83

471390.19

6231503.77

66

0

470330.36

5760113.58

61.19

Life Table for AP Urban Females

1
1

10

5

0

1

94136.62

141.1

15

5

0

0.5.

0.01

0.99

93995.52

842.17

467872.18

5289783.23

56.28

20

5

0

0.5

0.01

0.99

93153.35

649.8

464142.26

4821911.05

51.76

25

5

0

0.5

0.01

0.99

92503.55

737.08

460675.06

4357768.79

47.11

30

5

0

0.5

0.01

0.99

91766.47

640.12

457232.05

3897093.73

42.47

35

5

0

0.5

0.01

0.99

91126.35

861.61

453477.72

3439861.68

37.75

40

5

0

0.5

0.01

0.99

90264.74

853.46

449190.05

2986383.96

33.08

45

5

0

0.5

0.01

0.99

89411.28

1331.19

443728.43

2537193.91

28.38

50

5

0.01

0.5

0.03

0.97

88080.09

2859.46

433251.81

2093465.48

23.77

55

5

0.01

0.5

0.07

0.93

85220.63

5723.93

411793.34

1660213.67

19.48

60

5

0.03

0.5

0.12

0.88

79496.7

9843.87

372873.85

1248420.33

15.7

12.57
10.19

I

)

65

5

0.05

0.5

0.21

0.79

69652.83

14395.86 312274.53

875546.48

70+

5

0.1

@NA

1

0

55256.98

55256.98 563271.95

563271.95

Region

Sex

Rural

Male
Female
Male
Female

Urban

Probability of Dying
5q0
0.1037
0.0932
0.0859
0.0558

9

)
23

7

dx

0.5

I
I

lx

45ql5

0.2979
0.23895
0.2744

0.1543

2>

Preliminary results of Disease Burden -NOT FOR QUOTATION 9 October 1995

Annexure II. APBD Disease List
I. Communicable, Maternal
A. Infectious & Parasitic

5

5

■3

-J

64

1. Rheumatic Heart Disease

32

2. Iodine Deficiency

65

2. Ischemic Heart Disease

33

3. Vitamin A

66

3. Cerebrovascular Disease

2

a. Syphilis

34

4. Anemias

67

4. PEMC

3

b. Chlamydia

II. Noncommunicable

4

c. Gonorrhea

A. Malignant Neoplasms

5

3. HIV

35

1. Mouth and Oropharynx

6

4. Diarrhoeal Diseases

36

2. Esophagus

5. Childhood Cluster

37

3. Stomach

70

71

H. Chronic Respiratory Diseases
68

1. COPD

69

2. Asthma
/. Diseases of the Digestive System

1. Peptic Ulcer Disease

7

a. Pertussis

38

4. Colon/Rectum

8

b. Polio

39

5. Liver

9

c. Diptheria

40

6. Pancreas

72

10

d. Measles

41

7. Trachea/Bronchus/Lung

73

11

e. Tetanus

42

8. Melanoma and Other Skin

12

6. Meningitis

43

9. Breast

74

1. Rheumatoid Arthritis

13

7. Hepatitis

44

10. Cervix

75

2. Osteoarthritis

14

8. Malaria

45

11. Corpus Uteri

76

9. Tropical Cluster

46

12. Ovary

15

a. Lymphatic Filariasis

47

13. Prostate

77

1. Dental Caries

16

10. Leprosy

48

14. Bladder

78

2. Periodontal Disease

79

2. Cirrhosis of the Liver

J. Diseases of the Gemto-Urinary
System
1. Nephritis/Nephrosis

2. Benign Prostatic Hypertrophy
A.'. Diseases of the Musculo-Skeletal
System

L. Congenital Abnormalities
M. Oral Health

11. Trachoma

49

15. Lymphoma

12. Intestinal Helminths

50

16. Larynx

III. Injuries

18

a. Ascaris

51

B. Other Neoplasm

A. Unintentional

3. Edentulism

19

b. Trichuris

52

C. Diabetes Melltus

80

1. Motor Vehicle Accidents

20

c. Hookworm

53

D. Other Endocrine

81

2. Poisonings

21

13. Japanese encephalitis

E. Neuro-Psychiatric

82

3. Falls

B. Respiratory Infections

54

1. MAD

83

4. Fires

22

1. Acute Respiratory Infections

55

2. BAD

84

5. Drowning

23

2. Otitis Media

56

3. Psychoses

85

6. Venamous animals and plants as
cause of poisoining

C. Maternal Conditions

57

4. Epilepsy

86

7. Foreign body and accidental
aspiration

24

1. Hemmorhage

58

5. Alcohol Dependence

87

25

2. Sepsis

59

6. Alzheimer's and other dementia

D



1. Protein-Energy Malnutrition

1. Tuberculosis

17

□-

31

2. STD's Excluding HIV

1

5
5

G. Cardiovascular Diseases

E. Nutritional/Endocrine

Perinatal

8. Electric Shock

B. Intentional

26

3. Eclampsia

60

7. Parkinson's Disease

88

1. Self-inflicted

27

4. Hypertension

61

8. Drug Dependence

89

2. Homicide and Violence

28

5. Obstructed Labor

F. Sense Organ

90

3. Legal intervention

29

6. Abortion

62

1. Glaucoma-related Blindness

24

Preliminary results of Disease Burden -NOT FOR QUOTATION 9 October 1995

5
T)

Annexure HI ESTIMATION OF CAUSE OF DEATH IN RUKAL AP
Distribution of as reported by SCD AP (1988-93)
SCD CODE

5

5

5
3

3
3

3
3

3

3

CAUSE OF DEATH

Females

Males

All

Not class.

100

ACCIDENTS & INJURIES NOT : CLASSIFIABLE

66

39

105

III

SNAKE BITE

53

36

89

112

SCORPION BITE

8

3

11

113

RABIES

19

14

33

121

DROWNING

71

55

126

122

FALL FROM HEIGHT

38

24

62

123

VEHICULAR ACCIDENTS

128

42

170

124

BURNS

20

46

66

130

SUICIDE

162

122

284

140

HOMICIDE

22

10

32

151

EXCESSIVE HEAT

8

15

23

152

EXCESSIVE COLD

0

0

0

153

NATURAL CALAMITY

10

13

23

200

MATERNAL: NOT CLASSIFIABLE

0

25

25

210

ABORTION

0

9

9

221

TOXAEMIA

0

13

13

222

ANAEMIA

0

13

13

231

BLEEDING OF PREGNANCY

0

28

28

232

MALPOSITION OF CHILD

0

8

8

233

PUERPERAL SEPSIS

0

5

5

300

FEVERS : NOT CLASSIFIABLE

225

223

448

311

MALARIA

8

6

14

321

INFLUENZA

14

22

36

331

TYPHOID

33

36

69

DIGESTIVE DISORDERS : NOT CLASSIFIABLE

35

28

63

G ASTRO-ENTERITIS

71

108

179

400

' 411
412

CHOLERA

4

5

9

413

FOOD POISONING

22

9

31

414

DYSENTERY

59

66

125

421

PEPTIC ULCER

64

28

92

431

ACUTE ABDOMEN

87

73

160

500

COUGHS : NOT CLASSIFIABLE

22

25

47

511

TUBERCULOSIS OF LUNGS

432

196

628

513

BRONCHITIS & ASTHMA

578

346

924

3

521

PNEUMONIA

31

20

51

530

WHOOPING COUGH

6

4

10

3

600

CNS DISORDERS : NOT CLASSIFIABLE

24

16

40

610

PARALYSIS

344

259

603

620

MENINGITIS

20

21

41

630

CONVULSIONS

76

64

140

700

CONGESTIVE & OTHER HEART DISEASES

156

99

255

710

ANAEMIA

87

98

185

730

HEART ATTACK

489

232

721

J



3

3

3

3
3
3

3
3

25

105

25

448

63

47

40

255



)
)

Preliminary results of Disease Burden -NOT FOR QUOTATION 9 October 1995

)

800

J

)

3

5
0

5

s

OTHER MEDICALLY CERTIFIED DEATHS

3

0
3

17

45
66

811

CIRRHOSIS & CHRONIC LIVER DISEASES

42

24

812

JAUNDICE

151

92

243

821

CHICKENPOX

0

1

I

822

MEASLES

8

21

29

823

LEPROSY

23

8

31

831

TETANUS

8

13

21

841

POLIOMYELITIS

2

3

5

851

MENTAL DISEASE

18

21

39

861

CANCER

189

251

440

871

DIABETES

55

28

83

881

HYPERPLASIA OF PROSTATE

15

9

24

882

URAEMIA

32

12

44

890

OBSTRUCTED HERNIA

4

0

4

900

INFANT DEATHS : NOT CLASSIFIABLE

213

176

389

910

PREMATURITY

174

146

320

922

CONGENITAL MALFORMATION

15

7

22

923

BIRTH INJURY

12

4

16

931

RESPIRATORY INFECTIONS OF THE NEW BORN
PERINATAL

87

79

166

932

CORD INFECTION

13

13

26

933

DIARRHOEA OF NEW BORN

41

49

90

1000

J
3

28

389

SENILITY

1357

1313

2670

2670

Total

5979

4791

10770

4042

Details of Unclassified deaths from SCD subjected to expert opinion and
field enquiry
Description

SCD code

No. subjected for
EO&FE
27

No. Classified

6

6

27

J

1.00
2.00

Accidents and injuries not classifiable
Maternal not classifiable

5

3.00

Fevers not classifiable

107

107 •

J .
J

4.00

Digestive disorders not classifiable

12

12

5.00

Coughs not classifiable

10

10

6.00

CNS disorders not classifiable

4

4

J

7.00

Congestive and other heart diseases

53

53

J

8.00

Bums

11

J

9.00

Causes peculiar to infancy not classifiable

11
71

68

J

10.00

Senility

139

136

440

434

J

TOTAL

J
26

a
Preliminary results of Disease Burden -NOT FOR QUOTATION 9 October 1995

$

SCD
Deaths
Codes
1.13 31.61

Algorithms used to classify the SCD estimated deaths responsible for >0.1%
%
Cum %
Diseases
Solution
0.29%

0.29%

Rabies

Added to Group la total

1.51

32.15

0.30%

0.59%

3

1.53

22.33

0.21%

0.80%

Excessive Heat Added to Unintentional Injuries (Group HJa) total
Natural
Added to Unintentional Injuries (Group IHa) total
Calamity

2
5

4.31

179.89

1.67%

2.47%

Acute Abdomen [Added to Digestive (Group D i) total

5.13

1321.68

12.28%

14.75%

Bronchitis &
Asthma

To follow the distribution of Bronchitis & asthma from 26

6.1

1217.91

11.34% 26.09%

Paralysis

> 45 yrs to include in Stroke. < 45 to distribute in meningitis and
encephalitis as per ICD distribution

6.3

158.21

1.48%

27.57%

Convulsions

<15 as per ICD distribution in meningitis & encephalitis 15-45Epilepsy, 45-60:50% epilepsy, 50% stroke, >60: Stroke ’

8.12

267.49

2.48%

30.05%

Jaundice

To distribute <5 yrs. under hepatitis and for the remaining age groups
to follow ICD age wise distribution of Hepatitis, Cirrhosis & Cancer
Liver

5
3

5

8.51

114.26

1.06% 31.11%

8.61

831

7.74% 38.86%

Mental Disease To include in 'Neuropsychiatric total
Cancer
To include in Cancer total

3
5
Y

)

5
1

1

27

7


countries

J

Preliminary results of Disease Burden -NOT FOR QUOTATION 9 October 1995

Annexure IV

3

ESTIMATION OF CAUSE OF DEATH LN URBAN AP

Algorithms used to classify the MCCD estimated deaths responsible for >0.1% in Urban AP
ICD Codes Deaths
%
Cum%
Disease discription
Solution
71
1092
0.16%
0.16% Rabies
To move over to Group la total
161

1378

0.21%

0.37% Malignant neoplasm of
larynx

To add to the APBD list

200,202,203

505

0.08%

0.45% All other Malignant
neoplasm of lymphatic and
haempoietic tissue

To combine with Hogdkins and
Leukaemias

190-199

5860

0.88%

264-269

4242

0.64%

1.33% Malignant neoplasm of other To proportionately distribute to all
and unspecified sites
listed cancer sites including 'other
cancers'
1.97% All other Nutritional
To move over to Group HE totals
deficiencies

286-289

658

0.10%

290

801

302,-316

1100

323-339,341344,346-359

10949

3

402^04

2154

3

401,405

4545

415-429

40846

0
0
0
0
0

0


3

3
3


3

3
3
3
3 ’

444

838

411-443,446448

1413

3
3

3
3

5

2.07% All other diseases of blood To move over to Group HE totals
____ and blood fonning organs
0.12%
2.19% Senile and presenile, organic To move over to dementias including
psychotic conditions
Alzheimers
0.17%
2.36% All other Mental disorders To add to Group HF(Neuropsychiatric)
for the present and to develop some
algorithm to get Alzheimers
1.65%
4.01% All other diseases of
To add to Group IIF(Neuropsychiatric)
Nervous System
for the present and to develop some
algorithm to get deaths due to
alcoholism and drug dependence
0.32%
4-33% Hypertensive heart Diseases To add to APED list
0.68%
5.02% All other Hypertensive
To add to Hypertensive diseases list
Diseases
6.16% 11.17% Diseases of Pulmonary
To add to the Group
Circulation and other forms IIG(Cardiovascular Total) for the
of heart disease
present and develop appropriate
algorithm on the basis of autopy series
from India
0.13% 11.30% Arterial embolism and
To add to the Group
thrombosis
IIG(Cardiovascular Total) for the
present and develop appropriate
algorithm on the basis of autopy series
from India
0.21% 11.51% Other diseases of Arteries,
To add to the Group
Arterioles & capillaries
IIG(Cardiovascular Total) for the
present and develop appropriate
algorithm on the basis of autopy series
from India

)

)
)

28

)
)

Preliminary results of Disease Burden -NOT FOR QUOTATION 9 October 1995

455

718

0.11%

11.62% Haemorrhoids

To add to the Group
IIG(Cardiovascular Total) for the
present and develop appropriate
algorithm on the basis of autopy series
from India

445,449,450,
456-459

982

0.15%

11.77% All other diseases of
Circulatory system

To add to the Group
IIG(Cardiovascular Total) for the
present and develop appropriate
algorithm on the basis of autopy series
from India

19367

2.92%

To use alogorythem developed on the
14.69% Bronchitis, Chronic and
unspecified emphysema and basis of observed relationship between
bronchitis and asthma in 26 developed
asthama
countries

511

725

0.11%

14.80% Pleurisy

To move to Group IIH(Respiratoiy) for
the present

488,489,497510,512-519

9638

1.45%

16.25% All other Diseases of
Respiratory system

To move to Group IIH(Respiratory) for
the present

560

2481

0.37%

16.62% Intestinal obstruction
without Mention of Hernia

To add to the APBD list

567

2103

0.32%

16.94% Peritonitis •

To add to the APBD list

530,534,536539,544-549,
554-559,561566,568-570,
572,573,576579

12466

1.88%

18.82% All other diseases of the
other parts of the digestive
system

To move to Group III (Digestive) total
for the present and to develop

591,593,595599

715

)
)

490-496

3

3

3

3

0.11%

algorithm

18.93% All other diseases of Urinary To move to the Group II J (Genito
Urinary) total
System

797

26624

4.01% 22.94% Senility without mention of To follow the standard algorithm
already developed under GBD to
psychosis
distribute to Group I& II

780-796,798,
799

44754

6.74% 29.68% All other sign symptoms and To follow the standard algorithm
already developed under GBD to
ill defined conditions
distribute to Group I& II

E900-E909rE
911-E918JE9
21JE923-E92
9

4072

0.61% 30.30% All other accidents including To add to Group Illa (unintentional)
for the present
late effects

5

E980-E981

7711

1.16% 31.46% Injury undetermained
whether accidentally or
purposely inflicted

To proportionately distribute to Group
Illa & IHb deaths

5

E970-E979

1136

0.17% 31.63% All other types of violence

To add to the Group IHb total and
include under War/legal intervention

5
J

5
5

5
5

3

29

Preliminary results of Disease Burden -NOT FOR QUOTATION 9 October 1995

Annexure V
Group

Communicable

O '

Quality of data available for APBD estimates1 I
___________ Disease

India

AP

Tuberculosis
STD excluding HIV
HIV

***

** *

Diarrhoea
Childhood cluster

***

**

**

Meningitis

o

***

Japanese Encephalitis
Hepatitis

A

A

AAA

AAA

AA

AA

A

A

o
o

Malaria

AAA

AAA

O

Filaria

AAA

AAA

Leprosy

AAA

AAA

Trachoma

AA

Intestinal Parasitcs

AA

AA

AAA

AAA

A

A

A

A

AAA

AAA

Enteric Fever

a
5

[Maternal
Perinatal



0

Nutritional

Acute Rcsp.Infections
Maternal
Perinatal
PEM

Anaemia
IDD

AAA

AAA

AAA

AAA

Vita. A deficiency

AAA

AAA

Good community based studies; ** Community based studies; * Hospital Based data

5
5
5 .

5

5

Quality of data available for APBD estimates1 II

■)

30

)

)

Preliminary results of Disease Burden -NOT FOR QUOTATION 9 October 1995

Group

Disease

Cancers

Cancers

India
**

Endocrinal

Diabetes

***

Neuro-psychiatirc

Major Affective Disorders

AP
*
AA

AA

Bipolar Affective Disorders

Psychosis

AA

Epilepsy

AA

Alcoholism

A

Drug dependence

A

Dementias
Sense organs

Cataract

AAA

AAA

AAA

AAA

Glaucoma

Cardiovascular

J

Rheumatic Heart disease
Ischaemic heart disease

Cerebrovascular disease

Peri Endo Myocarditis and
cardiomyopathies

0
0

5
5
5
J

J
J

Chronic Respiratory

COPD

A

Asthma

A

Peptic Ulcer

A

Cirrhosis of liver

A

Hernia

A

____________

Appendicitis

A

Genitourinary

Nephritis & Nephrosis

AA

Digestive

)

A

BPH
Muskulo Skeletal

[congenital

J

A

Oral Health

Rheumatoid arthritis

A

Osteoarthritis

A

Congenital

A

Dental carries

AAA

AAA

Periodontal disease

AAA

AAA

A

A

Eduntulism
AAA

Good community based studies; ** Community based studies; * Hospital Based data

)

31

(J d d

u u u d d d u w o" d d d <j d

A A z

d d d <j c/ </ d d q <j d' d

& MH

(j (J.

Preliminary results of Disease Burden - NOT FOR QUOTATION 18 May 1995
Annexure VI Disability Adjusted Life Years(DALYs)
REGI
ON
AP

DISEASE

N
o Sum

AP

ALL

ALLM

ALLF

MO

M5

M15

M45

M60

FO

F5

F15

F45- 4

-J

17,657,518

9,159,641

8,497,877.

3,395,371

754,549 2,511,708

1,318,827

1,179,187

3,297,589

665,098

2,476,426

915,340

I.Communicable, Maternal 8.
Perinatal

1,143,423

9,528,102

4,852,049

4,676,054

2.880,158

394,568

954,294

376,283

246,746

2,669,881

391,872

1,146,691

273,742

193,867

A. Infectious & Parasitic

4,513,587

2,571,091

1,942,496

1,025,683

271,704

798,072

320,827

154,805

919,953

243,123

494,903

1. Tuberculosis

183,085

101,433

1,370,483

910,529

459,953

12,156

46,750

489.094

252,985

109,545

8,373

37,968

233,567

128,505

91,155

51,540

31,776

59,379

1,144

284

29,910

394

_____ 44

1,001

500

56,999

793

____ 85

AP

2

AP

3

AP

4

AP
AP
AP
AP
/ AP

5

a. Syphilis

59,711

28,558

31,153

1,057

244

26,895

326

____ 36

944

260

6

29,323

b. Chlamydia

567

____ 59

24,226

2,769

21,457

_______ 6

____ 32

2,674

____ 50

8

192

7

c. Gonorrhea

__7

21,010

221

____ 26

7,219

450

6,769

______ 82

_____ 8

341

____ 17

__1

_____ 49

____ 48

6,666

_____ 6

_____ 1^

AP
AP
XX AP
AP
AP
AP
AP
/ AP_
AP
AP
AP
AP
AP

2. STD's Excluding HIV

8

3. HIV________________

9

4. Diarrhoeal Diseases

1C

5. Childhood Cluster

11

B. Respiratory Infections

21,402
1,207,987
818,806
118,387
96,821
8.503
358,030
237,065
207,971
152,601
49,654
39,766
39,766
39,510
24,501
150,564
81,267
36,741
32,555
57,766 '
1,825,738 "

1. Acute Respiratory
Infections

1.764,354
_______

a. Pertussis

12

b. Polio

13

c. Diptheria

14

d. Measles

15

e. Tetanus

16

6. Meningitis

17

7. Hepatitis

18

8. Malaria

19

9. Tropical Cluster

20

a. Lymphatic Filariasis

21

10. Leprosy

22

11. Trachoma

V/AP

23

AP

24

AP

25

b. Trichuris

AP

26

c. Hookworm

AP

27

AP

28

AP

29

12. Intestinal Helminths
a. Ascaris

13. Japanese encephalitis

12,939

8,463

267

____ 52

12,052

501

____ 68

274

____ 56

8,080

____ 42

____ 12

632,288

575,699

490,071

39,856

67,179

15,030

20,152

444,097

38,994

60,016

13,404

19,189

424,095

394,711

334,488

40,474

42,519

4,944

1,669

307,551

43,445

37.443

4.594

61,714

56,673

55,984

5,730

______ 0

' 0

_____ 0

51,149

5,524

51,602

45,219

50,421

1,021

160

44,176

902

4.145

3,312

841

205

835

181,154

155,888

20,988

______ 0

___ q
___ q

3,093

176,876

___ q
___ q
___ q

_____ 0

4,358

156,552

24,601

129,545

___ q ___ q
141
___ q
217 ___ q
___ q ____ c

107,520
83,909

68,883

11,895

42,154

4,944

1,669

52,581

11,583

37,085

4,594

124,063

56,369

29,857

32,312

3,739

1,785

47,156

14,294

20,023

1,855

580

89,807

62,793

49,545

6,551

23,761

7,250

2,700

31,798

3,752

20,181

4,489

2,574

28,344

21,310

5,227

4,514

16,178

1.919

506

3,878

3,860

11,725

1,461

385

25,176

14,590

______ 0

_____ 0

10,227

13,789

1,160

______ 0

_____ 0

_____ 0

12,434

2,156

25,176

14,590

______ 0

_____ 0

10,227

13,789

1,160

______ 0

_____ 0

___ q

12,434

2.156

19,370

20,140

2,071

15,900

1,121

254

____ 24

2,032

16,855

1,094

131

8,715

______ 0

_____ 0

3,880

2,826

2,008

___ q

____ 27

15,786

_____ 0

7,494

1,328

6,965

76,063

74,501

306

61,471

12,491

1,254

541

301

59,571

12,959

560

41,290

39,977

306

40,984

______0

_____ 0

___ q

_____ 0

18,064

______ 0

18,383

225

____ 70

39,676
17,859'

_____0

18,677

___ q
301
___ q ___ q

1,110

0

16,460

______ 0
25,379'

2,104

12,266

1,184

541

___ q

1,044

560

4,755
60,325 ~

5,911
100,751 '
100,751 '

1,000
30,221 '

456
80,731 '

13,974

2,035
2,216'

139
12,820'

____ 65

16,096
37,501 '

3,018

495

562

646,956

68,843

83,300

31,365

30,221 '

73,662

80,731

616,520

68,843

83,300

31,365

73.662

921,613 ~
890,665

20,265
904,125"
873,689 ’

649,584
618,637'

60,325

32

1,678

_____ 0
_____ 0

___ q
___ q
1,678

I
*

CT

I

/

(j' 0* C' C1

O

I

J J d J (J u u d d d u (jd d d u (j a u M (J (J

G' C O' C* ’<J

Preliminary results of Disease Burden - NOT FOR QUOTATION 18 May 1995
AP

30

AP

31

AP

2, Otitis Media__________

61,384

C. Maternal Conditions

32

1. Hemmorhage

AP

33

2. Sepsis

AP

34

AP

35

AP

38

AP

37

AP

38

AP

39

AP

40

30,947

30,436

498,163

0

498,163

0

0

27,245

£

27,245

£

0

169,389

0

169,389

0

0

3. Eclampsia

4,623

0

4,623

0

4. Hypertension

6,308

0

6,308

0

5. Obstructed Labor

125,808

0

125,808

0

6 Abortion ,

37,012

0

37,012

0

0

0

0

D. Perinatal Conditions

1,778,021

937,262

840,759

937,262

___£

_____ 0

_____ 0

D. Nutritional/Endocrine

912,593

422,083

490,510

267,630

62,539

55,470

25,235

1. Protein-Energy
Malnutrition

374,260

188,358

185,903

178,789

1,800

4,738

1,702

2,961

30,947

30.436

0

0

0

0

0

0

0

464,622

29,163

4,378

£

0

25,811

1,434

0

£
£

£

156,273

13.115

0
01

'0

0

0

0

4,552

72

0

0

0

0

0

6,308

0

0

0

0

0

0

115,518

10,290

0

0

0

_____ 0

35,820

1,192

0

_____ 0

840,759

___£ ___ £

0

0

11,209

262,213

79,907

103,867

30,130

14,393

1,257

1,773

177.529

2,682

2.856

677

2,159

824

387

39,728

1,973

3,031

329

239

0

0

£
£
£

0
0

0

0

0

0

0

0

£

0

0

AP

41

2. Iodine Deficiency

91,683

46,383

45,299

40,510

AP

42

3. Vitamin A

37,660

19,324

18,336

19,324

0

0

18,336

AP

• 43

4. Anemias

408,990

168,018

240,972

29,007

59,037

47,771

23,154

9,048

26,620

AP

44 II. Noncommunicable

AP

45

AP

___ £ ___ £

___ £ ___ £

0

0

75,252,

97,980

29,125

11,995

5,288,634

2,849,878

2,438,757

301,009

119,392,

821,191

791,123

817,163

260,576

102,481

745,160

552,500

778,041

A. Malignant Neoplasms

595,259

304,933

290,326

7,645

6,336

102,889

120,194

67,869

2,274

2,366

108,414

132,726

44,546

46

1. Mouth and Oropharynx

48,307

32,205

16,103

• 0

0

9,571

14,191

8,442

0

0

6,270

7,115

2,718

AP

47

2. Esophagus___________

67,634

40,196

27,439

0

0

12,683

18,453

9,060

0

0

10,148

11,988

5,302

AP

48

3. Stomach

59,861

40,579

19,282

2

6

13,868

16,734

9,970

0

0

7,236

9,137

2,908

AP

49

4. .Colon/Rectum

26,296

15,121

11,175

0

24

3,122

7,528

4,447

29

71

1,810

6,125

3,140

AP

50

5. Liver

22,310

15,779

6,530

126

190

3,933

8,774

2,755

28

94

1,593

3,231

1,585

AP

51

6. Pancreas

13,021

8,259

4,761

0

0

1,850

4,058

2,351

O'

26

1,454

2,376

906

AP

52

7.
T rachea/Bronchus/Lung

64,529

55,845

8,684

30

24

17,687

27,856

10,248

28

28

921

5,648

2,060

AP

53

8. Melanoma and Other
Skin

1,663

934

729

13

31

196

407

287

52

6

210

316

145

AP

54

9. Breast

56,808

0

0

0

0

1

2

23,913

27,210

5,683

10. Cervix_________ ,

84,364

___ 0

0

_____ 0

0

0

32,830

42,727

8,806

56

11. Corpus Uteri

5,545

_____ 0

£

;0

_____ 0

0

0

2,394

1,539

1,612

AP

57

12. Ovary_______________

12,349

_____ 0

0

_____ 0

_ ____ 0

72

72

5,184

5,715

1,305

AP

58

13. Prostate____________

11,903

11,903

0


__ £
_J£•
_J£!

0

AP

£
£

£

55

56,808
84,364
5,545
12,349
____ 0

0

AP

190

2,715

8,998

0



_____ 0

___£

0

AP

59

14. Bladder

11,111

6,899

4,212

__ 0

___ 24

1,362

2,659

2,854

__ 29

70

317

1,139

2,658

AP

60

15. Lymphoma

83,864

59,962

23,902

7,473

6,037;

34,399

7,765

4,287

2,036

1,997

11,816

4,456

3,596

AP

61

16. Larynx______________

25,694

17,251

8,443

____ 0

0

4,029

9,053

4,169

___ 0

0

2,316

4,004

2,123

AP

62

B. Other Neoplasm

11,142

7,357

3,785

731

639

5,054

558

374

259

96

2,653

522

254

AP

63

C. Diabetes Melltus

118,907|

67,165

51,743

66

115

17,100

21,830

28,053

0

30

13,990

12,108

25,614

0

33

I d d d d u u d J d d (j (

j

(j

.

d d <j <j u

,



-

(j O' o o‘ o O' d d d d d

d (J

!.

h

Preliminary results of Disease Burden - NOT FOR QUOTATION 18 May 1995
AP

64

D. Other Endocrine______

1,091

663

428

___ 66

____ 38

337

150

____71

____ 0

0

153

AP

65

E. Neuro-Psychiatric

915,987

478,911

437,076

14,619

40,002

273,818

83,230

67,243

13,532

26,704

286,262

AP
AP"

66

1. MAD_______________

255,457

85,506

169,950

____ 0

_____ 0

73,194

10,128

2,185

____ 0

_____ 0

145,187

67

2. BAD_______________

17,122

8,660

8,462

____ 0

0

7,528

928

204

____ 0

_____ 0

AP

66

3. Psychoses__________

178,392

82,404

95,988

___ 23

116,

76,448

3,708

2,109

__ 25

139

AP

69

4. Epilepsy____________

152,529

90,673

61,856

9,917

36,200

38,718

3,641

2,198

6,757

24,260

AP

70

5. Alcohol Dependence

• 142,976

125,106

17,869

0

____ 0

69,954

38,657

16,496

_____ 0

0

AP

71

6. Alzheimer's and other
dementia

149,503

74,141

75,362

4,668

3,455

3,727

22,906

39,385

6,724

2,232

7,311
93,003
26,823
9,904
2,502

119
52,890
20,122
921
733
2,653
5,551
20,355

AP

72

7. Parkinson's Disease

13,272

7,428

5,844

11

21

80

2,743

4,573

25

0

64

2,379

3,376

AP

73

8. Drug Dependence

6,737

4,993

1,745

__ 0,

211

4,169,

520

___ 93

0

73

1,469

176

___ 27

AP

74

F. Sense Organ_________
160,080

81,232

78,848

843

0

8,460

40,946

30,983

823

0

6,660 • 36,969

34,396

AP

75

1. Glaucoma-related
Blindness

32,916

18,860

14,056

0

0

1,513

14.204

3,143

0

0

0

10,405

3,651

AP

76

2. Cataract-related
Blindness

127,164

62,372

64,792

843

0

6,947

26,742

27,840

823

0

6,660

26,564

30,745

AP

77

G. Cardiovascular
Diseases

1.855,050

959,952

895,098

19,820

13,196

131,374

305,706

489,857

23,341

21,553

120,433

199,344

530,427

AP

76

1. Rheumatic Heart
Disease

169,503

58,929

110,573

981

6,274

20,598

15,729

15,348

1,481

7,332

27,801

35,286

38,673

AP

79

796,479

487,627

308,853

250

121

64,251

171,388

251,617

157

134

16,473

64,919

227,169

AP

80

622,440

282,178

340,262

4,331

2,850

40,568

65,954

168,475

4,331

5,138

45,426

69,837

215,530

AP

81

AP

82

AP

83

1. COPD

AP

84

2. Asthma

AP

85

AP

86

AP

87

AP

86

AP

89

AP

90

AP

91

2. Ischemic Heart Disease

3. Cerebrovascular
Disease
4. PEMC

__________

156
57,688
4,641

230

2,088

1,362
2,415
43,549

266,628

131,218

135,410

14,259

3,952

5,957

52,635,

54,416

17,372

8,949

30,734

29,302

49,053

. 291,341

160.364

130,976

13,625

24,564

34.615

31,438

56,121

12,240

18,729

37,126

31,046

31,836

155,604

93,051

62,553

8,157

2,192

6,140

23,655

52,907

7,135

1,596

4,673

67,314

68,423

5,468

22,372

28,476

7,784

3,215

5,105

17.132

32,453

475,609

333,473

142,136

12,136

4,544

158,975

118,414

39,404

5,751

3,757

66,677

21,141
9,905
41,147

28,008

135,737

1. Peptic Ulcer Disease

94,457

339

826

33,503

20,107

7,737

458

666

16,919

9,538

4.364

263,570

62,512
189,000

31,944

2. Cirrhosis of the Liver

74,570

2,432

1,436

82,954

76,062

26,117

2,983

2,652

31,755

26,505

10,676

202,769

121,319

81,450

4,411

21,411

23,143

46,982

25,372

2,702

21,508

27,608

15,697

13,935

H. Chronic Respiratory
Diseases



I. Diseases of the Digestive
System

J. Diseases of the
Genito-Urinary System

1. Nephritis/Nephrosis

3,828

24,804

169,131

87,681

81,450

4,411

21,402

23,136

21,420

17,312

2,702

21,508

27,608

15,697

2. Benign Prostatic
Hypertrophy

13,935

33,638

33,638

0

0

8

7

25,562

8,060

0

.0

0

0

0

K. Diseases of the
Musculo-Skeletal System

54,242

18,296

35,946

0

1

11,565

5,304

1,426

.0

0

20,772

12,490

2,684

34

/

d d d d <

u/

U7

kJ

kU

V4/

kJ

kJ

kJ

kJ

W

kJ

kJ

'J

W

*

kJ

kJ

Preliminary results of Disease Burden - NOT FOR QUOTATION 18 May 1995
AP

92

1. Rheumatoid Arthritis

18,074

8,411

9,663

0

0

7,023

854

533

0

0

6,829

2,287

547

AP

93

2. Osteoarthritis

36,168,

9.885

26,283

______ 0

__ 0

4.542

4,450

893

0

____ 0

13,942

10,203

2,137

AP

94

L. Congenital Abnormalities

461,397

243,084

218,313

225,752

5,947

11,119

229

_____ 37

198,390

5,249

13,476

1,131

_____ 68

AP

95

M. Oral Health

145,760

73,128

72,632

1,294

2.601

42,741

16,139

10,353

1,264

2,489

40,936

16,311

11.632

AP

96

1. Dental Caries

25,356

12,807

12,549

1,294

2,601

5,500

2,170

1,243

_

2,489

5,267

2,151

1,378

AP

97

2. Periodontal Disease

90,382

45,889

44,493

___ q

0

6,491

2,157

______ 0

0

6,434

2,391

AP

98

3. Edentulism

30,022

14,432

15,590

o

AP

99 III. Injuries

2,840,781

1,457,715,

1,383,066

214,204

AP

100

A. Unintentional

2,343,779

1,181,261

1,162,517

210,652

AP

101

1. Motor Vehicle
Accidents

279,704

210,234

69.470

18.012

____ 0
240,588
221,230
40.299

37,241
_ ___ 0
736,223
526,176
128,455

AP

102

2. Poisonings

34,361

14,178

20,183

2,989

1,971

7,699

1,262

256

2,228

1,319

14,252

1,873

511

AP

103

3. Falls

899,015

371,961

527,054

70,974

68,502

107,781

41,803

82,901

282,524

61,831

34,593

15,001

133,104

AP

104

4. Fires

394,584

124,944

269,640

36,833

13.412

64,417

7,870

2,411

7,673

28,152

213,779

14,061

5,976

AP

105

5. Drowning

200,649

129,193

71,456

29,070

43,586

48,175

6,018

2,345

8,801

25,960

28,106

4,035

4,553

AP

106

6. Venamous animals and
plants as cause of poisoining

120,249

79,214

41,036

3,334

27,345

39,658

8,348

529

0

11,642

21,902

5,644

1,848

AP

107

7. Foreign body and
accidental aspiration

35,394

21,341

14,053

17,780

3,560

0

0

0

14,053

0

0

0

0

AP

108

8. Electric Shock

65,439

65,439

0

AP

109

B. Intentional

497,003

276,454

220,549

AP

110

1. Self-inflicted___________

371,196

199,855

171,341

AP

in

2. Homicide and Violence

113,630

68,274

45,356

AP

112|

3. Legal intervention

12,177

8,325

3.852|

_ 0
3,552
101
2.596
855

7,479

6,953

0

0

151,421

115,278

367.132

170,745

115,479

107,724

363.910

163,174

35,668
____ 0
584,575
407,334

18,388

5,081

9.288

19.896

23,817

7,727

7,863

89,098

171,516

60,741

167,358

6,783

9,686

0

49,436

13,435

2,568

0

0

0

0

0

19,358

210,047

35,942

7,554

3,223

7,571

177,241

28,357

4.158

14,064

155,610

24,471

5,609

__ 34

6,925

148,740

12,715

2,926

4.608

48,170

10,980

1,920

2,307

178

26,245

15,424

1,202

687

6,266

492

24

881

468

2,256

218

29

35

(JUUUUUUUUUWUUUU (J

u

U

M

u

V

Preliminary results of Disease Burden - NOT FOR QUOTATION 18 May 1995
REGIO
N
Rural

DISEASE

N

0 Sum________________________

ALL

ALLM

ALLF

14,037,909 7.184.267 6,853,642 2,688,456

M45

M15

M5

MO

M60

612,608 1,911,313 1,008.885

F45

F60

573,104 1,932,551

737,666

889,365

145.657

F15

F5

FO

963,005 2,720,956

7,781,109 3.921.409 3,859,700 2.320,412

324,217

769.944

301.541!

205.295 2,191^67

340,807

952.455

229.014

A. Infectious & Parasitic

3,805,990 2,137,602 1,668,388

881,835

222,379

646,586

257,194

129,608

806,747

210,391

419,525

155,826

75,900

I. Tuberculosis
~2. STD's Excluding HIV

1,137,636

743,935

393,701

10,369

39,279

397,492

205,334

91.461

33,328

203,783

112,278

37,288

70,950

24,170

46,780

882

198

22,768

296

26

7,023
78?

402

45,090

460

47

21,881

24,732

834

170

20,610

247

20

749

221

23,449

287

26

Rural

1 I Communicable, Maternal &

Rural

2

Perinatal__________________ _

Rural

3

Rural

4

Rural

5

a. Syphilis______________

46.614

Rural

6

b. Chlamydia

18,654

1,984

16,670

3

23

1.914

38

6

5

146

16,331

168

20

7

c. Gonorrhea
8 ~~ 3. HIV

5,682

305

5,377

45

5

244

11

1

28

35

5,310

4

1

12,020

7,674

4,345

201

35

7,080

311

48

214

47

4,050

26

8

Rural

9

4. Diarrhoeal Diseases

1.024.113

531.358

492.755

413.358

32,015

55,835

12.396

17,753

380,519

34.424

51,159

11.158

15,495

Rural

10

5. Childhood Cluster

739,942

379,914

360,027

303,700

35,343

35,394

4,021

1,456

282,318

40,455

32,165

3,764

1,327

104,456

54,109

50,347

49,646

4,453

0

0

0

45,839

4,508

0

0

0

707

115

0

0

Rural
Rural

Rural

11

a. Pertussis

75,725

40,034

35,691

39,113

796

125

0

0

c. Diptheria

7,208

3.667

3,542

2,850

702

114

0

0

2,674

724

144

0

0

168,832

174,813

148,920

19,911

0

0

0

150,770

24,043

0

0

0

Rural

12

b. Polio

Rural

13

34,869

Rural

14

d. Measles

343.644

Rural

15

e. Tetanus

208.908

113,273

95,636

63,171

9,471

35,154

4,021

1,456

48,166

10,473

31,906

3,764

1,327

106,627

74,389

48,677

25,057

28,092

3,197

1,603

41.213

13,224

17,866

1,602

484

1.903

Rural

16

6. Meningitis

181.016

Rural

17

7. Hepatitis___________,

137.261

79,399

57,862

47,113

5,583

18,983

5,639

2,081

30,843

3,574

17,748

3,794

8. Malaria

46,368

26,360

20,009

5,046

4,092

14,997

1,755

471

3,723

3,643

10,961

1,336

345

Rural

Rural
Rural

18
19

20

9. Tropical Cluster
a. Lymphatic Filariasis

27.726

17,292

10,434

o1

0

6,745

9.672

875

0

0

0

8,847

1,587

27,726

17,292

10,434

0

0

6,745

9.672

875

0

0

0

8,847

1,587

1,498

12,327

787

100

21

802

192

19

0

0

2,777

2,129

1,607

0

0

5,391

1,012

5,459

58,102

240

47,033

9,713

995

485

238

46,036

10,464

864

501

14,734

18,375

6,513

11,862

116,567

58.465

21

10. Leprosy______________

28.820

Rural

22

II. Trachoma

1,510

11,564

14,086

Rural

Rural

23

12. Intestinal Helminths

Rural

24

a. Ascaris

63,716

32,223

31,493

240

31,983

0

0

0

238

31,255

0

0

0

b. Trichuris

26,975

13,622

13,353

0

13,407

163

52

0

0

13,189

115

49

0

25,876

12,620

13,256

0

1,643

9,550

943

485

0

1,592

10,348

815

501

42,310

27,132

15,178

18,451

3,267

4,406

682

326

10,326

1,826

2,346

337

344

1,409,260

703.767

705,493

495,509

43,658

76,188

22,582

65,829

505,255

58,291

65,002

23.715

53,230

1,363,428

680,843

682,584

472,586

43,658

76.188

22,582

65,829

482,346

58,291

65.002

23,715

53,230

Rural

25

Rural

26

c. Hookworm

Rural

27

13. Japanese encephalitis

Rural

28

B. Respiratory Infections

Rural

29i

1. Acute Respiratory
Infections

36





(J (J ui J J J J J J'd d' (J <ji

!

»



—■



J d d d <J

J J (j

•«

----- —------------ i

------ —

*

(j (j

.

|



(j'd

Preliminary results of Disease Burden - NOT FOR QUOTATION 18 May 1995
45,833

22,923

22,909

22,923

o

o

o

o

22,909

o

o

0

o

411,882

0

411,882

0

0

0

0

0

0

0

385,018

22,486

4,378

1. Hemmorhage

20,015

0

20,015

0

0

0

0

0

0

0

18,944

1.072

0

33

2. Sepsis__________

130,816

0

130,816

0

0

0

0

0

0

0

121,013

9,803

0

Rural

34

3. Eclampsia

3,342

0

3,342

0

0

0

0

0

0

0

3,288

54

0

Rural

35

4. Hypertension

5,767

0

5,767

0

0

0

0

0

0

0

5,767

0

0

Rural

36

5. Obstructed Labor

96,138

0

96,138

0

0

0

0

0

0

0

88,447

7.691

0

Rural

37

6. Abortion

31,649

0

31,649

0

0

0

0

0

0

0

30.758

891

0

Rural

38

D. Perinatal Conditions

1,387,682

725,972

661,710

725,972

0

0

0

0

661.710

0

0

0

0

Rural

39

E. Nutritional

766,295

354.068

412,227

217,094

58.180

47.171

21,765

9,858

218,056

72,125

82.910

26,987

12,149

Rural

40

1. Protein-Energy
Malnutrition

312,139

154,391

157,747

147,584

1,139

3,754

536

1.379

. 151,507

2.516

2.115

356

1,253

Rural

41
~42

2. Iodine Deficiency

67,524

33,926

33,599

29,582

1,236

2,176

616

316

29,362

1,532

2,280

250

174

Rural

3. Vitamin A

26,810

13,808

13,001

13,808

0

0

0

0

13,001

0

0

0

0

Rural

43

4: Anemias

359,822

151,943

207,880

26,120

55,804

41,241

20,614

8,163

24,185

68,077

78,514

26,382

10,721

Rural

44 II. Noncommunicable
75 A. Malignant Neoplasms

3,960,604 2,104,230 1.856,374

204,066

79,738

581,702

585,469

653,255

191,764

78,735

566,635

435,762

583,478

Rural

30

2. Otitis Media

Rural

31

C. Maternal Conditions

Rural
Rural

32

Rural

457,662

222,954

234,708

4,361

4,060

68,544

89,706

56,283

1,526

1,946

87,988

109,161

34,087

Rural
Rural

46

1. Mouth and Oropharynx

36,707

24,058

12,648

0

0

6,804

10,505

6,749

0

0

4,620

5,622

2,406

47

2. Esophagus

52,163

30,237

21,926

0

0

9,130

13,801

7,306

0

0

8,359

9,611

3,956

Rural

48

3. Stomach

45.432

30,146

15,286

1

4

9,815

12,359

7,966

0

0

5.887

7,250

2,149

Rural

49

4. Colon/Rectum

20,205

11,365

8,840

0

23

2,218

5,715

3,409

29

55

1,454

4,840

2,462

Rural
Rural

50

5. Liver
6. Pancreas

16,871

11,721

5,150

60

113

2,819

6.519

2,210

28

78

1,299

2,576

1,170

9,91’8

6,160

3,758

0

0

1,291

2,991

1,878

0

26

1,181

■ 1,888

662

Rural

7. Trachea/Bronchus/Lung

45,384

38,470

6,914

30

24

7,352

21,000

10,065

28

27

758

4,552

1,549

Rural

52
53

1,263

696

567

7

19

139

301

229

33

5

171

251

107

Rural

54

9. Breast

44,520

0

44,520

0

0

0

0

0

0

1

18,394

22,401

3,723

Rural

55

10. Cervix

71,762

0

71,762

0

0

0

0

0

0

0

27,623

36,793

7,347

Rural

56

11. Corpus Uteri

4,519

0

4,519

0

0

0

0

0

0

0

2,064

1,239

1,216

Rural
Rural

57

12. Ovary_____

9,995

0(

9,995

0

0

0

0

0

29

. 56

4,281

4,533

1,097

58

13. Prostate

9,555

9,555

0

0

0

140

2,007

7,407

0

0

0

0

0

Rural

59

14. Bladder

8,333

5.197

3,137

0

23

958

1,966

2,249

29

54

246

836

1,972

Rural

60

15. Lymphoma

61,559

42,487

19,072

4,262

3,853

25,021

5,869

3,483

1,350

1,644

9,775

3,595

2,708

57

8. Melanoma and Other
Skin

37

Il

u u

|J(J(J(JUU(JU(J(JWW(JUUUUUU</UUUU

V

Preliminary results of Disease Burden - NOT FOR QUOTATION 18 May 1995
Rural

61

16. Larynx

19,476

12,862

6,615

5,623

3,067

462

0

2,857

6,673

3,332

o

o

1,876

3,174

1,565

443

3,985

435

298

172

80

2,227

409

178

0

Rural

62

B. Other Neoplasm

8,690

Rural

63

C. Diabetes Melltus

87,116

48,202

38.913

0

0

12,404

13,557

22,241

0

0

12,195

8,097

D. Other Endocrine

0

0

0

0

0

0

0

0

0

0

0

0

Rural
Rural

64

65

E. Neuro-Psychiatric

18,622

~

0

670,817

349,027

321,790

9,698

28,588

196,423

52,662

5.335

19,775

207,824

40,216

61,765

123.425

0

0

52,387

61.656
7,630'

44,640

1,748

0

0

104,449

15,338

3,638

Rural

66

1. MAD

185,190

Rural

67

2. BAD

12.394

6,248

6.146

0

0

5,387

697

163

0

0

5,265

704

178

Rural

68

3. Psychoses

128.493

59,190

69,303

12

71

54,688

2,735

1,685

16

114

67,059

584

1,530

Rural

69

4. Epilepsy

112,245

65,678

46.567

7,128

26,271

27.790

2,735

1,755

4.950

17,772

20.765

2.037

1,042

Rural

70

5. Alcohol Dependence

104,518

91,405

13,114

0

0

51,024

28,292

12,088

0

0

7,280

4.070

1,764

2,049

15,556

33,904

2.567

Rural

71

6. Alzheimer’s and other
dementia

113.689

55,992

57.697

2,552

Rural

72

7. Parkinson's Disease

10,241

5,787

4,454

6

8. Drug Dependence

4,046

2,962

1,084

0

Rural

73

2.642

17,188

31,505

4.353

13

57

2.057

3,655

16

0

52

1,819

130

2,448

321

62

0

53

906

108

17

2,105

1,835

128,167
64,905
F. Sense Organ_____________

63,262

609

0

6,415

32,040

25,841

602

0

5,133

29.333

28,194

25,087

14.296

10,791

0

0

1,083

10,700

2,514

0

0

0

7.931

2,860

Rural

74
75

Rural

76

2. Cataract-related
Blindness____________________

103,080

50,608

52,472

609

0

5,332

21,340

23,327

602

0

5,133

21,402

25,334

Rural

77

G. Cardiovascular Diseases

1,411,033

730,950

680,084

11,022

8,825

93,323

226,382

391,398

15,215

17,017

96,366

157,540

393,945

Rural

78

1 Rheumatic Heart
Disease________________ ,

128,610

43,570

85.040

580

4.479

14,645

11.607

12,259

980

5,541

22.082

28.091

28,346

Rural

79

2. Ischemic Heart Disease

607,506

373,934

233,571

143

78

45,634

127,029

201,050

104

106

13,108

51,141

169,112

475.112

216,603

258,508

2,469

1,835

28,811

48.873

134,615

2,865

4,073

36,193

55,041

160,337

Rural

1. Glaucoma-related
Blindness____________________

Rural

80

3. Cerebrovascular Disease

Rural

81

4. PEMC

199,806

96,842

102,964

7,830

2,433

4,233

38.872

43,473

11,266

7,297

24,984

23,266

36,151

Rural

82 H. Chronic Respiratory
D i s e a s es_____________________

216,529

117,314

99,214

7,856

16,608

24,666

23.339

44,845

8,092

14,361

28,611

24,386

23,765

Rural

83

1. COPP__________________

117,293

70,018

47,276

4,497

1,363

4,355

17,527

42.276

4,639

1,295

3,784

16,669

20,889

Rural

84

2. Asthma_________________

99,235

47,296

51,939

3,359

15,246

20,310

5.812

2,569

3,453

13,066

24,827

7,717

2,876

232.575

104,119

1,542

1,480

112,745

86,849

29,960

2,379

2,710

49,271

31,459

18,301

24,694

190

572

23,848

14,935

6,182

297

522

13,168

7,482

3,224

20,869

1,948

2,127

25,450

20,889

7.968

1,812

16,712

21,563

12,278

10,478

Rural

85

I. Diseases of the Digestive
System
_______________

336,694

Rural

86
~B7

• 1. Peptic Ulcer Disease

70,420

45,726

196,770

138,388

58,382

1,352

908

58,890

56,368

151,577

88,733

62.844

2,593

14,224

16,459

35,180

Rural
Rural

88

2. Cirrhosis of the Liver

J. Diseases of the
Genito-Urinary System

38

20,277

J J J J (J u J udd'Uwuu'dd u u u
i ’

'

'

'■

Preliminary results of Disease Burden - NOT FOR QUOTATION 18 May 1995
Rural

boTI

Rural

90

Rural

91

1. Nephritis/Nephrosis

125,871

63,027

62,844

2,593

14,219

16,454

15,925

13,836

1,812

16,712

21,563

12,278

10,478

2. Benign Prostatic
Hypertrophy

25,706

25,706

0

0

&

5

19,255

6,441

0

0

0

0

0

40.025

13.412

26,613

0

0

8,276

3,995

1,141

0

0

14,970

9.545

2,098

Rural

K. Diseases of the
Musculo-Skeletal System
92
1. Rheumatoid Arthritis

13,224

6,094

7,130

0

0

5,025

643

426

0

0

4.940

1,767

423

Rural

93

2. Osteoarthritis

7,318

19,483

0

0

3,251

3,352

714

0

0

10,030

7,777

1,675

Rural

94

L. Congenital Abnormalities

176,668

168,006

164,980

3,618

7.872

173

26

151,698

4,313

11,038

906

51

Rural

95

M. Oral Health

26,801
344.674 [
107.620j

53,868

53,753

943

1,891

30.591

12.159

8.283

932

1.820

29,450

12.433

9.117

Rural

96

1. Dental Caries

9,400

9,261

943

1,891

3,936

1,635

994

932

1,820

3,789

1.640

1,080

Rural

97

2. Periodontal Disease

33,270!

32,438

0

0

26,655

4.890

1,726

0

0

25,660

4.904

1,874

Rural

98

3. Edentulism

11,197

12,053

0

0

o

5,634

5,553

0

0

0

5.890

6.163

Rural

99 III. Injuries

2.296.196' 1.158,628 1,137,568

163,978

208,653

559,666

121.874

104.455

337.424

153,563

413.461

72.891

160,230

1,827,902

900,492

927,410

163,561

190,128

361.711

87,630

97,462

336,987

146,483

241,475

45.670

156,796
8.680

Rural

100

A. Unintentional

18.661 j
65.709'
__________ I
23,2501

Rural

101

1. Motor Vehicle Accidents

236.574

176,699

59.875

13,728

37,523

107.191

14,419

3,838

8,190

18.958

18,859

5,187

Rural

102

24,795

7.556,

17,239

1,578

1,082

4,088

675

132

1.577;

970

12,568

1,658

466

Rural

816,344

310,866

505,478

58,432

59,818

77.678

35,516

79,421

275,927

58,594

28,147

12,768

130,041

Rural

103
104

2. Poisonings
3. Falls
~
4. Fires

210,280

71,723

138,558

26,482

8.747

30,787

4,083

1,623

0

22,091

106,083

7.976

2,408

Rural

105

5. Drowning

189,028

120,294

68,734

27,554

42,116

43,126

5,319

2,179

8.251

25,658

26,555

3,878

4,392

Rural

106

6. Venamous animals and
plants as cause of poisoining

120.249

79,214

41,036

3,334

27.345

39,658

8.348

529

0

11.642

21,902

5.644

1,848

Rural

107

7. Foreign body and
accidental aspiration

35,394

21,341

14,053

17,780

3,560

0

0

0

14,053

0

0

0

0

Rural

108

8. Electric Shock

0

0

0

0

Rural

109

B. Intentional

Rural

110

Rural

Rural

65,439

65,439

0

0

0

49,436

13,435

2,568

0

468,294

258,136

210,158

418

18,525

197.955

34.244

6,994

437

7,080

171,987

27,221

3,433

1. Self-inflicted

364.121

195,226

168,895

0

14.026

151,690

24.021

5.489

0

6,850

146,703

12.491

2.853

111

2. Homicide and Violence

98,439

59,005

39,433

0

4,165

43,460

9,888

1,493

0

0

24,265

14.600

567

112

3. Legal intervention

5.734

3,905

1,829

418

334

2,806

335

12

437

230

1,019

130

13

39

Preliminary results of Disease Burden - NOT FOR QUOTATION 18 May 1995
REGI
ON

N

DISEASE

ALL

ALLM

ALLF

MO

M5

M15

M45

M60

FO

F5

F15

F45

F60

Urban

0 Sum

3.619,609 1.975,375 1.644.235

706 915

141.941

600.395

309,942

216.182

576.634

91.994

543.875

Urban

1 I. Communicable. Maternal &
Perinatal

1.746,993

177.674

254,058

559.747

70.351

184.349

74.742

41,451

478,114

51.066-

194,237

44.728

48.209

Urban

2

Urban

3

Urban

4

A Infectious & Parasitic
1. Tuberculosis

2. STD’s Excluding HIV

930.639

816.354

I
I

707,598

433,489

274,108

143,847

49.325

151,486

63,633

25,197

113,206

32.732

75,378

232,847

166,595

27.259

25.533

66.252

1,787

7.471

91.602

47,651

18,083

1,350

4,640

29,784

7,606

16.227

12,599

14.251

262

86

7,142

98

18

220

98

11,909

334

39

20,205

Urban

5

a. Syphilis

13,097

6.677

6,420

223

74

6.285

79

16

195

Urban

6

b. Chlamydia

39

5,874

5.572

279

785

4,787

33

3

9

760

12

1

3

46

4,680

53

6

Urban

7

c. Gonorrhea

1,536

144

1,392

37

3

97

7

0

Urban

8

3. HIV

22

9,383

4.118

2

0

66

17

___ ]?!_

1,355

5,265

4.972

190

20

60

____ 9l.

4,030

15

4

Urban

9

4. Diarrhoeal Diseases

183.875

100,930

82,945

76.713

7.841

11,343

2,633

2.399

63.578

Urban

10

5. Childhood Cluster

4.570'

78,865

8,857

44.181

2.246

3.694

34,684

30,789

5,131

7.125

923

213

25,233

2,991

5,279

830

351

Urban

77

a. Pertussis

13,931

7,605

6,326

6,339

1,266

0

0

0

Urban

12

b. Polio

5,310

1.017

21,096

0

11,568

0

9,528

0

• 11,309

225

35

0

0

9,308

194

27

0

0

Urban

13

c. Diptheria

1,294

691

604

461

139

91

0

0

Urban

14

d. . Measles

419

14,386

111

8,045

74

6.341

0

0

6.968

1,077

0

0

0

5,782,

559

0

0

0

Urban

15

e. Tetanus

28.157

16.272

11.885

VI3

2.424

7.000

923

213

Urban

16

6. Meningitis

4,414

26,956

1,110

17,436

5,179|

9.519

830

351

7.692

4.801

4.220

542

182

5.942

1,070

2.157

10.409

4.931

254

97

2.431

969

4.778

1.611

620

956

177

2,433

1.984

694

1,301

671

182

422

1,180

164

36

155

218

764

7.883

124

4.156

41

0

0

3,483

4,117

284

0

0

0

3.587

569

Urban
Urban
Urban

17

18
19

7. Hepatitis

8. Malaria
9. Tropical Cluster

15,340
3.285
12,040

Urban

20

a. Lymphatic Filariasis

12.040

7.883

4,156

0

0

3,483

4,117

284

Urban

10. Leprosy

0

21

0

10,689

0

5,283

3.587

5.406

569

561

4,336,

319

63

5

534

4.528

6.125

307

2,201

31

3.924

6

0

0

1,103|

697

401

0

33,997

0

2,103

17,598

316

16.399

1,506

67

14,438

2,778

259

56

64

13,535

17,552

2,495

9,067

246

8,485

59

67

9.000

0

0

0

64

9.766

8,421

0

5,055

4.711

0

0

0

4.976

62

18

0

0

4.670

24

17

0

Urban
Urban

Urban
Urban

22
23

24
25

11. Trachoma
12. Intestinal Helminths

a. Ascaris
b. Trichuris

Urban

26

c. Hookworm

6,679

3,476

3.203

0

462

2,716|

241

56

Urban

27

13. Japanese encephalitis

0

15.456

444

2,471

10,369

229

5,087

59

6,927

1,488

1,505

318

130

3,648

390

672

158

218

Urban

28

B. Respiratory Infections

416,477

217.846

198.632

154,075

16,667

24,564

7,639

Urban

14,902

29

1. Acute Respiratory
Infections

141,701

400,927

10,552

209,822

18,298

191,105

7.649

146,051

20,432

16,667

24.564

7.639

14,902

134,174

10,552

18,298

7,649

20,432

40

I

(J (J J (J (J u d (J (J-J V’ V o

d d <J d q a d d d

u

d d d c/ c<

d d d u

Preliminary results of Disease Burden - NOT FOR QUOTATION 18 May 1995
lurban I

Urban
Urban
Urban
Urban !

Urban I
Urban ■

Urban j
Urban I
Urban |
Urban ,

30

2. Otitis Media

21

C. Maternal Conditions

32

1. Hemmorhage
2. Sepsis

33
34
~35

3. Eclampsia
4. Hypertension

5. Obstructed Labor
22
37'

6. Abortion

38"

15,551

8.024

7.527

8.024

0

0

0

0

7,527

86.281

0

86.281

0

0

0

0

0

0

0

7.230

0

0

0

0

0

0

38.572

7)

0

0

0

0

0

0

1,281

0

1.281

0

0

0

0

0

541

0

_541

0

0

0

0

0

29,670

0

29.670

0

0

0

0

0

5,363

0

5.363

0

0

0

0

0

7,230
38.572

0

0

0

0

79,604

6,677

(0)

0

6,868

362

0

0

35.260

3,312

0

0

0

1,263

18

0

0

0

541

0

0

0

0

27,071

2.599

0

0

0

5,062

301

0

0

D. Perinatal Conditions

390,339

211,289

179.049

211,289

0

0

0

0

179,049

0

0

0

0

146,299

68,015

78.284

50,535

4,360

8,299

3.470

1,351

44.158

7,782

20,957

3,143

2 244

__ J

D. Nutritional/Endocrine
40 "
1. Protein-Energy
Malnutrition

33.966

28.156

31,205

661

984

722

394

26.023

166

741

321

906

Urban •

41

2, Iodine Deficiency

24.159

12,458

11.701

10,928

Urban

466

785

208

42

3, Vitamin A________

72

10,365

441

750

79

65

10.850

5,516

5.335

5,516

0

0

0

0

5,335

0

0

0

0

49,168

16,075

33,093

2,887

3,233

6,530

2.540

886

2,435

7.175,

19,466

2.743

1.274

1.328.031

745.648

582,383

96,943

39,654

239,488

205.653

163,909

68,812

23,746

178,525^

116,738

194.563

137,597

81,979

55.617

3,284

2.276

34,345

30,489

11,586

748

420

20,425

23,565

10.459

11,601

8,146

3,455

0

.0

2,767

3,686

1,693

0

0

1,650

1,492

312

Urban
Urban

39’

43

44 II, Noncommunicable

Urban

45

Urban

46
~47

Urban

Urban
Urban
Urban
Urban

Urban
Urban
Urban

48

49
~50
51

53
54

56'

Urban
Urban

A. Malignant Neoplasms

1. Mouth and Oropharynx
2. Esophagus

3. Stomach
4. Colon/Rectum
5. Liver

6. Pancreas

H 7. Trachea/Bronchus/Lung

Urban
Urban

4. Anemias

58'

62.122

15,472

9,959

5.513

0

0

3,553

4.652

1,754

0

0

1,789

2,378

1.347

14,430

10,434

3,996

0

2

4.052

4,375

2.004

0

0

1.349

760

6.091

1,887

3,756

2.335

0

0

904

1,814

1,037

0

16

356

1,285

• 678

5,439

4.059

1,380

66

77

1,114

2,255

546

0

7e

295

655

415

2,099
17,375 '

1,004

0

0

559'

1,067

473

0

0

272

488

244

1,770

0

0

10,335

6,856

239

162

6

12|

57

106

184
~58

3,103

19.145~

0

0

163

1,095

511

18

1

319

65

39

0

0

0

5,519

4,809

1,959

0

0

0

0

5,207

5,935

1.460

0

0

K

0

0

350

300

395

0

0

0

0

43

17

9013

1,183

209

8. Melanoma and Other Skin
9. Breast

12,288

0

12,288

0

0

0

0

10. Cervix

12,602

0

12,602

0

0

0

1,026

0

1,026

0

0

0

2,354'

0

11. Corpus Uteri
12. Ovary
13. Prostate

Urban

59'

Urban

60’

15. Lymphoma_____

Urban [

61 ’

16. Larynx

14. Bladder

401

2,354 ‘
2,348

2,778 ’

22,304
6,218 ’

2,348

0

0

0

49

707

1,591

0

0

(0

0

0

1,702

1,076

0

0

404

694

604

0

16

71

302

686

17,474

4.830

3,211

2,184

9,378

1,897

805

686

353

2,042

861

889

4,389

1,829

0

1,172

2,380

837

0

0

44'1

830

558

41

__

U (J U (J (j .C V O (J C U

Preliminary results of Disease Burden - NOT FOR QUOTATION 18 May 1995
Urban

62

B. Other Neoplasm

2,453

1,735

718

270

196

1,069

123

77

87

16

426

113

76

4,696

8,273

5,812

0

30

1,796

4,011

6,992

119

156

Urban

63

C. Diabetes Melltus

31,792

18,962

12,829

66

115

Urban

64

D. Other Endocrine

1,091

663

428

66

38

337

150

71

0

0

153

Urban

65

E. Neuro-Psychiatric

245,170

129,884

115,286

4,921

11,413

77,396

21,574

14,581

4,197

6,929

78.438

12.674

13,048

Urban

66

1. MAD

70,266

23,742

46,525

0

0

20,807

2,498

437

0

0

40,737

4,784

1.003

Urban

67

2. BAD

4,728

2,412

2,316

0

0

2,141

230

41

0

0

2,046

2T7

52

Urban

68

3. Psychoses

49,899

23,214

26,685

10

45

21,761

973

424

9

25

25,945

149

558

Urban

69

4. Epilepsy

40,284

24,995

6.488

6.058

616

320

15,289

2,789

9,929

10.928

906

443

1,807

4,407

0

0

2,625

1,480

651

453

4.799

9.644

560

810

Urban

70

5. Alcohol Dependence

38,457

33,702

4,756

0

0

18.930

10,364

Urban

71

6. Alzheimer's and other
dementia

35,814

18.149

17,665

2,116

1,350

1,085

5,718

7,880

2,372

396

Urban

72

7. Parkinson's Disease

3,030

1,640

1,390

5

8

23

686

918

9

0

.12

Urban

73

1,720

199

31

0

20

563

68

9

Urban

74

6,201

Urban

75

Urban

2,691

2.031

660

0

81

31,912

16.327

15,585

234

0

2,045

8,906

5,142

221

0

1,527

7.636

1. Glaucoma-related
Blindness

7,828

4,563

3,265

0

0

430

3,504

629

0

0

0

2.474

791

76

2. Cataract-related
Blindness

24,084

11.764

12.320

234

0

1,615

5,402

4,513

221

0

1,527

5,162

5,411

Urban

77

G. Cardiovascular Diseases

215,015

8,798

4,371

38,051

79,324

98,459

8,126

4,535

24,068

41.805

136.481

Urban

78

10.328

8. Drug Dependence
F. Sense Organ

444,017

229,003

1. Rheumatic Heart Disease

40,893

15,359

25,534

401

1,795

5,953

4,122

3,089

501

1,790

5,719

7,195

107

43

18,616

44,359

50,567

53

28

3.365

13.778

58.057

1.065|

9.233

14.796

55.194

Urban

79

2. Ischemic Heart Disease

188,974

113,692

75,282

Urban

80

3. Cerebrovascular Disease

147,329

65,575

81,754

1,861

Urban

81

4. PEMC

66,822

34,377

32,445

6,429

Urban

82

74,812

43,050

31,762

5,769

Urban

83

38,310

23,033

15,277

3,660

Urban

84

36,502

20,017

16,485

2,109

Urban

85

I. Diseases of the Digestive
System

138,915

100,898

38,017

10,593

3,064

46,230

31,566

9,444

3.372

Urban

86

1. Peptic Ulcer Disease

24,037

16,786

7,251

149

254

9,656

5,171

1,556

Urban

87

2. Cirrhosis of the Liver

66,801

50,612

16,188

1,079

528

24,064

19,694

5.247

Urban

88

51,192

32,586

18,606

1,818

7,187

6,685

11,802

5,095

890

4,796

Urbgn

89

43,261

24,655

18,606

1,818

7,183

6,683

5,495

3,476

890

4,796

H. Chronic Respiratory
Diseases
1. COPD

2. Asthma

J. Diseases of the
Genito-Urinary System

1. Nephritis/Nephrosis

1,015

42

11,757

17,081

33,860

1,466

1,518

1,724

13.762

10,943

6,105

1,652

5.750

6.035

12.903

7,956

9,949

8,100

11,276

4,148

4,368

8.515

6,661

8,071

830

1,784

6,128

10,631

2,496

301

889

4,472

7,119

7,126

8,165

1,972

646

1,652

4,067

2,188

951

1.047

7,626
7MG7

9,687

6.503

160

144

3.751

2.056

1,140

1,035

525

6,305

5,616

2.708

6.045

3,418

3,457

6,045

3,418

3,457

a

>

J J J (J (J U <J c/ c/ o u .c o (7 o' O U U Q </ <7 o O 0 O’ (J O O •</ O. O O O o O </' c/ o' '

Preliminary results of Disease Burden - NOT FOR QUOTATION 18 May 1995
Urban

90

2. Benign Prostatic
Hypertrophy

7,932

7,932

0

0

3

2

6,307

1,619

0

0

0

0

0

Urban

91

K. Diseases of the
Musculo-Skeletal System

14,217

4,884

9,333

0

0

3,289

1,309

286

0

0

5,802

2,945

586

Urban

92

1. Rheumatoid Arthritis

4,850

2,317

2,533

0

0

1,998

212

107

0

0

1,890

520

124

Urban

93

2. Osteoarthritis

9,367

2,567

6,800

0

0

1,291

1,098

179

0

0

3,912

2,426

462

Urban

94

L. Congenital Abnormalities

116,723

66,416

50,308

60,773

2,330

3,246

56

10

46,692

936

2,438

225

17

Urban

95

M. Oral Health

38,140

19,260

18,879

351

709

12,150

3,981

2.070

322

669

1 1.486

3.878

2.515

Urban

96

1. Dental Caries

6,695

3.407

3,288

351

709

1,563

535

248

332

669

1,478

511

298

Urban

97

2 Periodontal Disease

24,673

12,619

12,055

0

0

10,587

1,601

431

0

0

10,008

1,530

517

Urban

.98

3 Edentulism

6.772

3,235

3.537

0

0

0

1,845

1,390

0

0

0

1,837

1,700

Urban

99 III. Injuries

544,585

299,087

245,498

50,225

31,935

176.557

29,547

10,823

29.708

17,183

171,114

16,207

1 1,286

515,877

280,770

235,107

47.091

31,102

164,465

27,849

10.263

26.922

16,692

165,859

15,071

10.562

43,130

33,536

9,595

4,285

2,775

21,264

3,969

1,243

1.098

938

4,957

1.596

1,005

Urban

100

Urban

101

A. Unintentional
1. Motor Vehicle Accidents

Urban

102

2. Poisonings

9,566

6,622

2,944

1,411

889

3,610

587

125

651

349

1,684

215

45

Urban

103

3. Falls

82,670

61,095

21,575

12,542

8,683

30,104

6,287

3,479

6,597

3,237

6,446

2.233

3,062

Urban

104

4. Fires

184,303

53,221

131,082

10,351

4,665

33,630

3,787

788

7,673

6,060

107,696

6.085

3,568

Urban

105

5. Drowning

11,621

8,900

2,722

1,516

1,470

5,049

699

166

550

303

1,551

157

161

Urban

106

6. Venamous animals and
plants as cause of poisoining

0

0

0

0

0

0

0

0

0

0

0

0

0

Urban

107

7. Foreign body and
accidental aspiration

0

0

0

0

0

0

0

0

0

0

0

0

0

Urban

108

8. Electric Shock

0

0

0

0

0

0

0

0

0

0

0

0

0

Urban

109

B. Intentional

28,709

18,318

10,391

3,135

833

12,092

1,698

560

2,785

491

5,254

1,136

724

Urban

110

1. Self-inflicted

7,075

4,629

2.446

101

38

3,920

449

121

34

76

2,037

224

74

Urban

111

2. Homicide and Violence

15,191

9,269

5,923

2,596

443

4,711

1,092

427

2,307

178

1,980

823

634

Urban

112

3. Legal intervention

6,443

4,420

2,023

438

352

3,461

156

13

444

237

1,237

88

16

43

J

3
3
3

Preliminary results of Disease Burden -NOT FOR QUOTATION 9 October 1995

Annexure VII

3
3

TUBERCULOSIS

3
3
3 '
3
5
5

9

Tuberculosis is one of the major infectious diseases in India. A wealth of epidemilogical

data is avaialble in the country due to significant contributions made by two pioneering
institutions the National Tuberculosis Institute (NTI) and the Tuberculosis Research Centre

(TRC). In addition to the wide ranging studies undertaken by these institutions, longitudianl
studies have been undertaken by Pamra et al in New Delhi and Fromot Moller et al in Andhra

)

Pradesh. Few cross sectional studis undertaken in different parts of AP provide useful information

5
3

on TB prevalence in the State.

i

Natural History

>

Tuberculosis is caused by Mycobacterium tuberculosis, which most commonly affects the
lungs. The infection is usually transmitted from persons with pulmonary tuberculosis to other

5

persons by droplets . The bacilli reaching the lungs cause a local non-specific inflammatory
response known as primary complex in the lung and in the corresponding lymph nodes. In most

instances both the lesions of the primary complex heal spontaneously leaving dormant bacteria
>

which may get reactivated during the later part of the life. Thus, the clinical disease may occur

)

weeks to years after primary infection. The usual incubation period from infection to primary
lesion is between 4-12 weeks. Allergy and immunity against tuberculosis are produced within

)

6-8 weeks. This results in formation of granulomas around the focus of bacilli. The most

)

important aspect of the natural history of the tuberculosis is that infection may lead to relatively

»
)

small proportion of cases at a later date. Occasionally, in case of new borne and small children,


the infection may progress resulting in serious forms of tuberculosis such as milliary tuberculosis


or tuberculous meningitis. Rarely the infection is through the digestive tract due to consumption
of contaminated milk containing Mycobacterium bo vis from cows suffering from tuberculosis

I. Steps for the estimation:
To beginwith a detailed review of epidemilogical studies on Tuberulosis was undertaken
and core expert was identified This is followed by a two day workshop. Participants included
Core expert, Disease experts, Programme managers and Public health Specialists. The following

44
8

■xS

3
3

Preliminary results of Disease Burden -NOT FOR QUOTATION 9 October 1995

3
3
3

steps have been followed to estimate the incidence , duration and case fatality rates of

3

tuberculosis in Andhra Pradesh.
1. Case definition for adult pulmonary and extrapumonary tuberculosis was arrived at.

3
3

3
3

3

3
3
3
3
>

3
3

>

>
>

>

«

2. The age specific incidence pattern of tuberculosis (but not necessarily the magnitude) was
determined using the data from cohort stuides undertaken in India.

3. A review of trends of Tuberculosis over the last 30 years was undertaken.
4. Adjustment factors for screening method were arrived after establishing relationship of
true prevalence to different screening methods.

5. Adjustment factor for extrapulmonary tuberculosis were arrived after establishing
relationship between prevalence of pulmonary tuberculosis and extrapulmonary
tuberculosis.
6. Prevalence of pulmonary tuberculosis in rural AP was estimated from studies after
adjusting for deficiency in screening method.
7. Estimates of age specific remission (or duration) and
J
u T SpeC
remission (or Oration) and case fatality rates were made using
a anapa e ata after adjusting for improved remission rates reported from recent
evaluation study of district TB control'programme.

8. Cause specific deaths due to TB were estimated from SCO and MCCD data sets.

9. The age sex specific incidence pattern (step 2), remission & case fatality rate (step 7) and
cause specific deaths (step 8) were used as inputs to DISMOD. By an Iterative process the
incidence rates were adjusted to match close to the estimated prevalence and cause
specific mortality for urban and rural AP.
Case definition

1. Pulmonary tuberculosis:
In epidemiological surveys a case of pulmonary tuberculosis is identified on the basis of

smear positivity (either on direct
- - mr
microscopy or culture) and or X-ray abnormality suggestive of
tuberculosis. All the cases diagnosed on the basis of X-ray abnormality need not be due to
tuberculosis. Reliability and validity of X-ray readings have been demonstrated to be low by

various epidemilogical studies. The cohort studies undertaken by Tuberculosis Research Centre
(BCG trial), and National Tuberculosis Institute included only the bacillary cases for arriving at
the incidence of tuberculosis. In addition to satisfying Koch's postuales, a smear positive case

requires identification and treatment on a priority basis to reduce the chances of further spread.
Also, untreated smear negative cases would eventually become smear positive. Hence, only the
bacillary cases were included for estimation of incidence and prevalence of pulmonaiy

45

Preliminary results of Disease Burden -NOT FOR QUOTATION 9 October 1995

o
o
o
o
o-

o'
o
o
o
o
o
o
o

tuberculosis among the adults in A.P. However, in case of children suffering from pulmonary
tuberculosis, due to difficulty in obtaining sputum samples, bacillary cases alone may not reflect

. .. the true burden.

.

The BCG trial, after undertaking a detailed review, has defined bacillary case of
tuberculosis as : a) cases positive on two cultures b) cases positive on one culture only and c)
cases positive on smear only, excluding those showing 1-3 Acid Fast Bacilli on entire smear

The BCG trial classified an individual whose sputum is positive on smear and negative on
culture as a bacillary case of tuberculosis. The ICMR-National Sample Survey and NTI studies
did not classify individuals who are positive on direct smear and negative on culture as cases of

tuberculosis. We have used the BCG trial definition for the bacillary cases for the following two

reasons. If the the time lag between the collection of the sample and setting up the culture is
longer, the chances of getting a negative culture will be more even in the presence of bacilli. The

second factor is the strength of NaoH used for preparing the sputum for culture. A stronger

0

NaoH may destroy the live bacilli and hence may not yield a positive culture. Since the definition



of the bacillary case already excludes the sputum samples demonstrating 1-3 bacilli in the entire

3

smear, it is less likely that there is a reading error in smear examination. Hence, it is desirable to

D

include the smear positive and culture negative cases for epidemiological estimates.

3

2. Extrapulmonary tuberculosis:

)

All cases diagnosed on clinical an'd or X-ray basis as suffering from active extrapulmonary
tuberculosis have been included in this group.
Age sex distribution of Tuberculosis incidence:

The four cohort studies provide information on incidence of tuberculosis in India have


been summerised in Table 1. These include Tuberculosis Prevention Trial undertaken by

Tuberculosis Research Centre (TRC), Madras. NTI study near Bangalore (1961-68)', Frimodt
Moller'S study in Madanapalle’ (1930-55) and Pamra's study in Delhi’. A summary of these studies

is presented in the Table 2.1
473-W7 Tuberc ■l0S'S ln a rUral populatlon of South lndia: a five year epidemiological study, NTI, Bangalore; Bull. WHO 1974, 51. pp.
t

Pp 61-17C)J Fr'mOdt M°"er' A COmrT’un'ty Wlde luberculosis study in a south Indian rural population, 1950-55; Bull WHO 1960, 22.
i

vol., No,2. ppXeT

Chan9eS

PreVa'enCe

inCidenCe °f pulmonary 'oberculosis in Delhi in recent years; Ind. J. Tuberculosis

46

Preliminary results of Disease Burden -NOT FOR QUOTATION 9 October 1995

Table 2.1 Review of Tuberculosis incidence studies undertaken in India
BCG trial
Study
NTI
Madanapalli
Pamra
Year

1968

Study location

Tamil Nadu

Karnataka

Area

Chingleput district

119 randomly
Population residing
selected villages from within 10 miles of
three taluks of
Madanapalli town
Banglore district
including accessible
villages and small
towns

Population covered

1961-68

1950-55
Andhra Pradesh

1962-70
Delhi
Urban Population
under surveillance of
New Delhi
Tuberculosis centre

360000

62000

60,000

30,0000

Duration

7.5

5

6

8

No. of follow-up
rounds
Duration between
two follow-up
rounds (yrs.)

3

3

4

3

2.5

1.5-2

0.7-1.6

2-2.5

AU individuals > 5
yrs

All individuals > 5
years

Eligibility criteria

All individuals >10 All individuals > 5
yrs____________
yrs_____________
Methodology
Initial X ray. Film
Initial X ray. Film
read by two readers read by two
From individuals
independent readers
whose films
From individuals
interpreted as
whose films
abnormal by either of interpreted as
two readers sputum abnormal by two,
specimens were
any of two and
collected and
technically
subjected to direct
inadequate two
microscopy and two samples of sputum
cultures
collected and
subjected to direct
microscopy and
culture
Definition of a case Eligible individual
Eh’gible individual
with a normal X-ray who was culture
at the intake aijd .
negative with normal
becomes smear /
or abnormal X ray in
culture positivelater all the preceding
surveys and who
becomes culture
positive with X ray
abnormality in
current survey
Crude
131-366
13,1-176
incidence/1000

47

Initial MMR
Initial X ray. Film
Film read by one
read by two
experienced reader
independent readers
X ray abnonnals
From Individuals
subjected for larger X whose films
ray and smear direct interpreted abnormal
microscopy
by either of readers
Sputum culture only sputum samples
for admitted cases
collected and
subjected for direct
microscopy and
culture.

Fresh cases detected
after an initial
normal MMR.
Separate analysis
done for bacillary
(direct smear) and X
ray abnonnals.

Fresh case among
previously X ray
negative. Separate
analysis done for
bacillary (direct
smear & culture) and
X ray abnonnals.

16-49

90-100

Preliminary results of Disease Burden -NOT FOR QUOTATION 7 October 1995

In all the studies reviewed (except Pamra's study) the incidence tended to increase with

3
3
3
3

age. This is in sharp contrast with'the total absence of peak in young adulthood (between 25-30

yrs) generally noticed in the west4'. This brings out the issue to what extent the new cases
occurring in the later parts of adult life are due to new infection or due to flare up of old

'3,

endogenous infection acquired earlier. Fimodt Moller observed that 66% of the new cases

3

detected at Madanapalle had an earlier tuberculin reaction of 10 mm or more suggesting that

3*

majority of the new cases could be due to reactivation of old infection. Review of NTI data by

3
3

W Krishnamurthy et al" also had shown that 72% of the new cases came from a reservoir of
previously infected population. Since a large reservoir of infected cases are existing in the

community, it is not surprising to notice that most of the incidence cases occur with advancing

3

age when the resistance of an individual is likely to go down there by resulting in reactivation of

3
3
3
3
3
3
3
3

existing infection. Though Pamra's study shows a peak in the younger age groups, the study

covered a population residing in urban slums of Delhi which is more likely to be biased towards

younger and fit individuals. Hence, we have decided to follow the incidence pattern and need not
necessarily the magnitude of TRC, NTI and Madanapalli studies.

Irdcteroecf tteukss (nfaes)
fa~ap3tdcf255egs(B3Gtrid, CTtpjpJ)

hxfenogcf titeaicss (fairies)

2ID|—

3
3
3
3
3 .

^1.

.411-

|tID2D -

| an-

I■P °L*'M

3

Z» S41
XAs

XAc

3 ■

3
J

3
3

3
)

Cochrane AL Cox J G and Jarman T F; 1955 British Medical Journal 1.. 371

s

Groth Peterson,E. Knudsen J el al 1957 Nord Med 58 1361

.

Knshna Murthy et al. Incidence of Tuberculosis among newly infected population and in relation to the duration of infected

status, Indian J Tuberculosis Vol. XXIII No.1.

1
)

48

'S

Preliminary results of Disease Burden -NOT FOR QUOTATION 7 October 1995

3

d

'IrdcfeTEcfTBikTnNn sLd/. Fera
an
tD ■

C>

O

tota -

14D

o
ffl-

o1-1-

3

4)514

514

■534

3554

XAs

3

5
5

Though Madanapalle study was from A.P. the population covered in each age group is
small and nearly four decades have passed since the survey. Pamra's study is also confined to a
small urban population of 30,000 which is influenced by urban migration. In the NTI study the

3

incidence was calculated from difference noticed between two prevalence surveys and hence

missed the new cases occurring between the surveys which either got cured or died. The TRC
study covered a large population and also ensured that new cases appearing between the surveys

5

are not missed. It is also more recent and hence provides a more realistic estimate of incidence.
We have used the age and sex distribution of incidence cases reported from the BCG trial.

Tuberculosis Trends:
=)

)

J

It is difficult to get correct data on occurrence of new cases of adult tuberculosis from the
same area on a continuous basis. Hence, prevalence of tuberculosis infection obtained through

repeated tuberculin testings in children, over a period of time, is recognised to be a reliable

indicator of tuberculosis incidence and its trend in a community7. This is considered to be
)
)
■)

independent of efficiency of tuberculosis control programme. A WHO study group 8 has
recommended that such survey can be undertaken once in five years.

■»

Styblo.K., Recent advances in epidemiological research in tuberculosis. Adv. Tuberc. Res. 20; 1980. 1.
WHO Report of the South East Asian Research Study Group on tuberculosis 1S81 p.11.
49

3
Preliminary results of Disease Burden -NOT FOR QUOTATION 9 October 1995

3

3
3
Recently the TRC has undertaken a study which followed up two panchayat unions

3
3

covered in the BCG trial and repeated tuberculin testing among the children aged 1-9 yrs.

3

Tuberculin testing was done twice at intervals of 10 and 15 yrs9. The results of the study have

3



clearly shown that risk of tuberculosis infection remained unchanged over a period of 15 yr. Risk

3

of new infection experienced by a child aged 1-9 yr. in 1984 was same as that experienced by his

3 .

counterpart 15 yr. Studies carried out in other parts of the country also suggest that the

3

tuberculosis incidence remained more or less constant. Gothi et al have reported that the

3

prevalence of tuberculosis infection remained constant over a twelve year period (1961-73)10. No

3

decline in prevalence of infection was noticed among the.children aged 0-9 yrs over a period of

3

five years (1974-79) in a study undertaken by Chakraborty et al in Bangalore district of Karnataka

3

state

3

No appreciable change in tuberculosis situation was noticed over a period of 15 yrs

(1962-77) in another study undertaken at Delhi12. In the state of Andhra Pradesh no such studies

1

were undertaken. However, considering the similarities in population characteristics,

5

socio-economic situation and geographical proximity of A.P. to Tamil Nadu and Karnataka, we
have assumed that the tuberculosis situation in A.P. also remained constant. This assumption

permitted us to compare the different studies undertaken in AP.

3

Adjustment for Screening methods:

9

Conventionally two screening methods are used to detect a case of tuberculosis in the

9

9

surveys. The yield of the tuberculosis cases in population based surveys is determined by the type

9

of screening method adopted. These screening methods are summarised herewith.

1. Initial screening of all eligible persons is done with X-ray. All those with X-rays read as
abnormal are subjected to sputum and/or culture examination. This approach will miss the
sputum positive cases which do not exhibit any radiological abnormalities.
)

2. The second approach, which is currently being followed in the National programme,
identifies the symptomatics first. The symptomatics are then subjected to sputum
examination followed by an X-ray. Since all the cases suffering from tuberculosis need not
be symptomatic, this approach will miss the asymptomatic cases.



)
)

Mayurnath S. et al. Prevalence study of tuberculosis infection over fifteen years in a rural population in Chingleput district

)
*
9

1
*
*

(south India); Indian J Med. Res. (A) 93, March 1991, pp 74-80
10

Gothi.G.D., A.K.Chakraborty et al., Prevalence of tuberculosis in a south Indian district- Twelve years after initial survey. Indian

J Tuberc. 26 (1979), pp 121.
ii

Chakraborthy A.K. et al, Tuberculosis in rural population of south India: Report on five surveys. Indian J Tuberc. 29 (1982), pp

152
12

Goyal SS et al Tuberculosis trends in an urban community. Indian J Tuberc 25 (1978) pp..
50

Preliminary results of Disease Burden -NOT FOR QUOTATION 9 October 1995

3

3
3
3
3
3
3

3. Another screening method used in few studies screened the symptomatics first and
subjected them to X-ray. Only symptomatics having abnormal X-rays were subjected to on
spot sputum microscopy. This screening method will miss the cases among asymptomatics
and also the symptomatic cases with normal X-rays.
If the relationship of cases to different screening methods is known, it will be possible to

3
3
3

North Arcot district, Tamil Nadu13 provides useful data to estimate this relationship. The results

3
3

About 25,688 individuals were included in the study out of whom sputum samples were

derive more accurate estimates of prevalence from almost all studies. A recent TRC study from

of this study help to estimate the missing cases.

collected from 6007 on the basis of symptomatic status or X-ray abnormality. The 205 sputum
positive cases detected from this study gives a prevalence of 800 per 100,000. If only X ray is

used for screening, 144 cases would have been identified which gives a prevalence of

560/100,000. Similarly if screening is confined only to detection of symptomatics it would yield

3

135 cases which gives a prevalence of 526/100,000. Thus, either methods of screening would

3
3

miss about a third of the existing tuberculosis cases. About a half of the smear positive cases did
■ not show any bacilli on direct microscopy and were detected on the basis of positive culture.

About 15% of the smear positive cases, though positive on direct-microscopy, did not yield any
positive culture. Based on these relationships we have arrived at adjustment factors to correct for
3

cases missed by each of the screening method.
Adjustment factor for type of screening procedure

3

Screening method

No. of
+ve
cases

Adjustm
ent
factor1

5

Symptom survey followed by smear e.xamination

73

2.8

5

Symptom survey followed by smear examination and culture

112

1,8

X-ray survey followed by smear examination for X-ray abnonnaIs

73

2,8

X-ray survey followed by smear examination and culture for X-ray abnonnals
Symptom survey followed by X-ray and smear examination for X-ray abnonnals
Symptom survey followed by X-ray. smear examination & culture for X-ray abnonnals
Total smear and culture positive cases
Tomi population

133

1.5

47
71

4,4
2.9

9

3
3

9

Total smear & culture positive cases/Cases detected by screening method

9

9
13

)

5

Tuberculosis prevalence survey in North Arcot District, Annual Report of TRC 1990 pp 107-118.
51

205
25688

<7

Preliininai'y results of Disease Burden -NOT FOR QUOTATION 9 October 1995

3

3

Establishing relationship between pulmonary and extrapulmonary
tuberculosis:

o


□'


Very little population based data is available on the prevalence of extrapulmonary

tuberculosis. The intensified case detection camp held in Bhadrachalam (A.P.) in 1982 shows that
out of the total tuberculosis cases detected, 15% were constituted by persons suffering from

extrapulmonary tuberculosis. An analysis of all tuberculosis patients attending different

departments at Gandhi Hospital, Hyderabad14 indicated that 16% of the total cases were
extrapulmonary. This, however, may not reflect the community situation. The pulmonary

tuberculosis patients are more likely to receive domicilliary treatment and only more complicated

5

cases tend to come to hospitals. On the contrary, higher proportion of extrapulmonary
tuberculosis patients will attend hospitals. We may not be far off from truth if we assume that one

out of three cases of pulmonary tuberculosis will attend hospital. In case of extrapulmonary
tuberculosis we can assume that either all the affected or at least half of the affected will attend

hospital. We have taken average of these two and applied this relationship to arrive at the
adjustment factor for extrapulmonary tuberculosis.

Adjustment factor for Extrapulmonary tuberculosis
Place

Pulmonary
Extra
pulmonary cases
cases

3

Total
cases

3

Hospital

84

16

1001

5

Community with higher prevalence of extrapulmonary
TB

2522

323

284

Community with lower prevalence of extrapulmonary TB

252

16

268

Community average

252

24

276

Adjustment factor for extrapulmonary tuberculosis
1

Total cases were assumed to be 100

2

Pulmonary cases in hospital X 3

3

1.1

Extrapulmonary cases in hospital X 2

2)
Review of TB prevalence studies from A.P.

Out of the published studies, the National sample survey (ICMR in 1953-58) is a large
scale study which followed a well standardised protocol. Recently, two population based surveys

were undertaken in the districts of Khammam and Medak by the TB control programme officers.

3
3

14

Personal communication from Dr.Eswariah, State TB Officer, Govt, of Andhra Pradesh

52

ICO

3

0 ?y49

CA
An

>

Preliminary results of Disease Burden -NOT FOR QUOTATION 9 October 1995

>
>

The emphasis of the Khammam study was on tribal population while the Medak study covered the

rural population. We have summerised these studies herewith.We, however, restricted the data
>

from these studies only to population above 15 yrs. to make them comparable with other studies.

>

This is also influenced by the fact that pulmonary tuberculosis is less common below 15 yrs.
1. ICMR National Sample Survey (1955-59):

>

The first major attempt to assess the magnitude of tuberculosis in the community was
undertaken by ICMR in 1955-59. The survey covered a population of 116,539,000 aged above

five years. Two zones (Hyderabad & Madanapalle) out of the total six zones covered in the study
included parts of A.P. Each zone was further stratified in to city, towns and villages. Entire

3

population residing at the selected sampling unit was listed. AU those above the age of five years
constituted the eligibles and were subjected to a miniature radiogram.. Each X-ray film was read

3

3
3

by two independent readers. A sample of the abnormals was sent to a central reader for
consistency check. Bacteriological examination (on spot specimen) was carried out in all cases

which were considered abnormal by one or both readers. The material collected for
bacteriological examination consisted of sputum (two slides) for direct smear examination,
sputum (2 tubes) for culture. If sputum was not available laryngeal swabs (2 tubes) were collected

for culture. The group that undertook the survey in Madanapalli zone was involved in the
3

tuberculosis control activities for a long time. Hence, the bacillary case yield was noticed to be

3

higher compared to Hyderabad zone. The reported prevalence of bacillary cases in Madanapalle

3

zone was 1144/100000 and 850/100000 in towns.and villages respectively.

5

3
5
3

3

3
3
3
3

2. Tuberculosis prevalence survey in Rural Medak district 1992:

To assess the prevalence of tuberculosis in the rural community a survey was undertaken

in Medak district during the year 1992. The study also aimed to understand the epidemiological
pattern of the disease and assess extent of utilisation of health services available for TB control.
The study was undertaken in thirty three villages selected by random sampling method. A

door to door survey was undertaken covering all the residents aged above five years in the

selected villages to identify chest symptomatics. NTI protocol which is standardised for health
workers bias was used for symptomatic survey. The proportion of symptomatics above the age of

3

15 yrs. reported in the study is comparable to that of North Arcot and Raichur studies

9

undertaken by TRC. On the spot sputum was collected and a single sputum examination done to

3

53

3

Preliminary results of Disease Burden -NOT FOR QUOTATION 9 October 1995

detect Acid Fast Bacillus (AFB) by Zeihl Nelson's stain. No culture or concentration techniques

have been used. During the second phase chest symptomatics identified were subjected to MMR.
The MMR was read by a single reader trained at National Tuberculosis Institute (NTI).

A total of 48,223 individuals were listed from the 31 villages covered. The total
population above 15 yrs was 30,863. Out of the population above 15 yrs. 1196 symptomatics

were identified. Out of the chest symptomatics identified 847 (70.82%) could be subjected for
sputum examination and successfill MMRs could be taken for 662 (55%). A total of 50 smear
positive cases were detected. This gives a prevalence rate of 162/100,000 for sputum positive

cases. The prevalence rates were higher among males (male female ratio = 7:3).
Summary of Mcdak study finding: ________
________ __________ Descrip t i o n
Number
Total population enumerated
48223
Population above 15 yrs.
30863
Chest symptomatics listed
1196
No. of symptomatics subjected to sputum examination
Prevalence of smear positives
No. of symptomatics subjected to MMR
~
~
No.of MMRs technically adequate
MMR Positives
Extra pulmonary tuberculosis

$



~ ~

Percent
100
3.9

847

70,82*

50

0.2

712

59,53*

631

52.76*

129

0.4

2

0

Expressed as percent of symptomatics listed

s>

3. Intensified TB case finding in Bhadrachalam Division, Khammam District
(1982):

2>

An intensified case finding activity was undertaken in Bhadrachalam division of Khammam


2)

district in 1982 by the TB control programme of A.P. Initial enumeration of population was done
to list the population aged above five years. A door to door survey was undertaken by the

2)

paramedics to identify the chest symptomatics among the listed population. The symptomatics

2)

listed were subjected to MMR. The films were read by one reader trained at NTI. Only the

3

individuals diagnosed to be having abnormal MMR were subjected to sputum examination which

3

included direct microscopy ofon the spot sputum sample. Out of the total 1,46,449 population

3

surveyed, 92,263 individuals above the age of fifteen years were listed. The screening for

3

symptomatics yielded 5,189 symptomatics. Out of the symptomatics listed 5,183 were subjected

3
3

54

Preliminai'y results of Disease Burden -NOT FOR QUOTATION 9 October 1995

for MMR. Among the individuals subjected for MMR, 1465 were diagnosed as radiologically
abnormal. Out of the 1465 radiologically abnormal individuals identified, sputum examination

was done for 1267 and 473 persons were detected to be smear positives. The study gives a
prevalence rate of 513/100,000. Out of the detected cases the male female ratio was around 2:1.
O
O
O

O

O

The prevalence of tuberculosis among tribals and non tribals was similar.

|
Summary of Bhadrachalam study findings
I
Description
Number
[Total population
146449
[Population above 15 yrs.
92263
Chest symptomatics listed
5189
No. of symptomatics subjected to MMR
5183
[MMR Positiyes
1465
No. of symptomatics subjected to onspot sputum exam
1267
Sputum positives
473
Extra pulmonary tuberculosis
84
* percent of symptomatics listed

Percent
100
5.6
99’.9*
1.6
24.42*

0.5
0.1

o


3
3

S
J

5
5

4. Prevalence of Tuberculosis after adjusting for screening methods in rural AP:
As a first step we have applied the adjustment factor appropriate for the type of screening

method used to estimate the true prevalence of TB .
Prevalence of TubercuIosis/1000 population
Survey
Before adjustment
After adjustment
ICMR Sample Sun’cy __ __________ 850 ____________ 1642
Medak survey
162
706
Bhadrachalam survey.
513
2832
5. Estimates for current prevalence of tuberculosis in rural A.P.

Out of the three studies, Medak study is most recent. The ICMR sample survey was

2

conducted nearly four decades back when there was no National programme for tuberculosis

2

control and anti tuberculosis drugs were not freely available. This makes it inconsistent with the

2

burden of disease methodology which estimates the burden at the current operational efficiency of

2

2
2
2

2

the intervention programme. The Bhadrachalam study was undertaken in tribal area. As the tribal

population constitutes about 6% of the total population of the State, the results of this study can
55

Preliminary results of Disease Burden -NOT FOR QUOTATION 9 October 1995

not be applied for the entire State. The population residing in tribal areas are included in the rural
population in census data. The rural population constitutes about 73% of the total State's
population. Out of the rural population, 8.65% was constituted by Scheduled tribes. We have
arrived at the mean prevalence of tuberculosis for rural population by applying prevalence rates of

Medak study to the non tribal rural population (91.35%) and prevalence rates of Bhadrachalam to
the tribal population (8.65%).

Estimated prevalence of TB in rural A.P.

= (706 X 0.9135) + (2832 X 0.0865)

= 890/100,000 adults
This estimate is close to the results of recent survey undertaken by TRC at Raichur district

o
o

in Karnataka15 ( 1090/100,000 population).
6.

3
3

Deriving age & sex specific incidence of Tuberculosis in rural and urban A.P.
using DISMOD

The burden of disease methodology requires estimation of age specific incidence and

O



duration of disability to estimate the DALYs lost. In addition, the consistency of epidemiological

3

estimates need to be checked. A disease model built on known relationships between different

3

epidemiological parameters by the Burden of Disease Unit (DISMOD) helps in achieving these

3

objectives. The model requires instantaneous remission and case fatality rates of the disease to be

3

used as inputs. Estimation of these instantaneous rates requires follow-up studies. Out of three

3

studies undertaken in rural south India, Madanapalle study was from Andhra Pradesh. It also

provides age specific data on remission and case fatality. The results of the study are presented in

the table.
Out come of the newly diagnosed cases on Tuberculosis
from Madanapally study



Age
group
5

15-24

25-34
35-44
45-54

55+

15

Initial 1st Year
cases No.died No.TB+
No.TB-

5th year

No.died No.TER No.TB167 ______ 14 _____ 54 ______ 99 ____ 40
34
93
337 _____ 22
129
186 _____ 93_
78
166
298 _____ 26
110
162
108 _____ 52
138
210
29 _____ 86 _____ 95
90
33
87
144
19
53
72
74
26
44

Tubercufosis prevalence in Raichur District Annual report cl Tuberculosis Research Institute (ICMR) 1989 pp 120-131. '
56

&

Preliminary results of Disease Burden -NOT FOR QUOTATION 9 October 1995

Out come of the newly diagnosed cases on Tuberculosis from
Madanapalle study (percent)
Initial 1st Year
Age
5th year
group cases Mortality Persistance Remission Mortality
Persistance Remission
rate
rate
rate
rate
rate
rate
15-24
167
8.38
32.34
59.28
23.95
20.36
55,69
25-34
337
6.53
38.28
55,19
27.6
23.15
49.26
35-44
298
8.72
36.91
54,37
36.24
17.45
46,31

$

45-54

210

13.81

40,95

45,24

42,86

15.71

41,43

55+

144

13.19

36.81

50

51.38

18.06

30.56

Instantaneous remission and case fatality rates were calculated from this data using the
outcome at fifth year.

Age specific instantaneous rates from
Madanapalle study
Age group
Instantaneous Instantaneous
remission
case fatality rate
15-24
0.23
0.1
25-34
0.19
0.11

o

o
o
o

35-44

0.2

0.15

45-54

0.18

0.18

3

55+

0.13

0.21

3

A1I

0.19

0.14

The Madanapalle study was undertaken in early sixties and subsequently there has been a

phenomenal change in Tuberculosis chemotherapy which may influence the outcome. Hence, we
have reviewed recent studies which assessed the outcome of newly detected tuberculosis cases.

5

Dr.Manjula datta et al

3

treatment under District Tuberculosis Control programme in North Arcot district, Tamil Nadu.

have assessed the outcome of 2257 smear positive cases registered for

This study also captures the outcome of the defaulters and hence consistent with the burden of
disease approach of estimating the disability and mortality at the current operational efficiency of
the intervention programmes. When we compared the aggregate remission and case fatality (after

excluding general mortality rate), we found that mortality rates of Madanapalle are comparable
with North Arcot while remission rates in North Arcot are 2.5 times higher. Though both cohorts
received treatment, the North Arcot patients had access to better Chemotherapy (69% received

18

Manjula Datta et al. Critical assessment of smear-positive pulmonary tuberculosis patients after chemotherapy under the

district tuberculosis programme. Tubercle and Lung Disease 74. 1993 pp 180-186.
57

3

M

Preliminary results of Disease Burden -NOT FOR QUOTATION 9 October 1995

Short Course Chemotherapy) which explains better remission. The marginal difference between

mortality rates could be due to the known observation that even INAH mono therapy has

favourable impact on mortality reduction. Considering the fact that Madanapalle study was
a

undertaken in Andhra Pradesh and provides age specific follow-up data we have used it as an
input to DISMOD after applying an adjustment factor of 2.5 to correct for current treatment

<

practices and patient compliance. While Madanapalle data on outcome is not available by sex ,
North Arcot study gives only information on deaths by sex. Hence, we have used NTI data to

arrive at adjustment factors for sex.
Using these instantaneous rates as inputs we have adjusted the instantaneous incidence

rates to get the best match for the estimated prevalence and deaths.

DISMOD outputs for Rural AP
Age group Male

Female

Annual
incidence/
100000

3
3

O

Annual
Annual age SCD
prevalence/ specific
estimated
100000
deaths
deaths

Annual
incidence/
100000

Animal
Annual age SCD
prevalence/ specific
estimated
100000
deaths
deaths

0-4

15,8

15.2 ______ 34

509

11.9

13.6 _____ 27

218

5-14

20

28

131

185

19

28,9

115

316

15-44

439,5

617,8

7775

•6268

233

45.7

1227.5

1846.8

9582

14296

655.2

1298.5

4166
5627

4199

45-59
60+

1555.5

2918.2

8385

9784

735.2

2078,4

All

465.1

714.7

25907

31042

248.2

532,3

3819
13754

10590
5296
20619

The DISMOD outputs suggest that ’we have to go for higher age specific incidence rates
than reported to arrive closer to the estimated deaths and prevalence. Even than the estimated

O
d

deaths are lower than the deaths estimated from Survey of Cause of Death suiweys. Considering

the fact that SCD data is based on lay reporting there is more likelihood of overestimating the

tuberculosis deaths we felt the DISMOD outputs are fairly representative of prevailing cause
specific mortality due to tuberculosis.

When we applied the same rates in urban areas, the death estimates were found to be very
high. Our estimates of prevalence are based on surveys undertaken in rural areas. Though the

National Sample Survey reported higher prevalence in urban areas, we felt that the urban residents
have better access to treatment and hence better remission rates. Hence, we have adjusted the
remission rates of the rural areas by a factor of 1.25 and then adjusted the incidence rates to

match the deaths estimated from MCCD data. These results are presented in table.


2

58

Preliniin:ii7 results of Disease Burden -NOT FOR QUOTATION 9 October 1995

DISMOD outputs for Urban AP
Age group Male

Female
Annual
Annual age MCCD
Annual
xAnnual
Annual age MCCD
prevalence/ specific
estimated incidence/ [prevalence/ specific
estimated
100000 • deaths
deaths
100000
100000
deaths
deaths
14,3
12.2 _______ 10
479
10,7
11.1
8
257

Annual
incidence/
100000

*3

0-4

3

5-14
15-44

3

3

45-59
60+
All

18

20.7

398,6
1019,2

470.3

36
2354

1301,3

2231

1666,1
388.4

2683
498.6

1881
6512

136

13,5

21.7

32 _______ 72

2370
2211

141
384

233.1
616.9

840
730

837
651

1867

881,9
163.2

211,5
301.7

1054
2664

1119
2936

7063

3

The estimated age specific incidence rates in urban areas are comparable with the

3

incidence rates reported from BCG trial. It is, however, evident that in both urban and rural areas,

3

3
3

3
3
3

the number of deaths reported in the Fess than 15 years are less than the reported deaths. In fact,

we tried to match the annual incidence rates in these two age groups as close as possible to the
age specific incidence reported from the longitudinal studies reviewed. Even then the DISMOD

estimated deaths remained much lower than the deaths estimated from registration schemes.

Tuberculosis experts often argue that it is difficult to get samples of sputum from this group.

3

Also, the proportion of extra-pulmonary forms of tuberculosis would be higher in this group

3

which are not captured by the community based surveys.

3
3

The outputs from DISMOD were used as inputs to the worksheets to estimate the Years

of Life Lost and Years Lived with Disability due to Tuberculosis.

3

3
3

£

J

)

Y

59

Preliminary results of Disease Burden -NOT FOR QUOTATION 9 October 1995

DIABETES MELLITUS
Diabetes mellitus is a common endocrinal disease resulting in several complications. Our

estimates are for Non-insulin dependent diabetes (NIDDM) which accounts for 80-90% of all
diabetes world-wide. While Insulin dependent diabetes (IDM) is considered to be relatively rate in

most developing countries the epidemiology of third form of diabetes, the malnutrition related

diabetes mellitus is poorly understood. The WHO case definition of diabetes is based on

biochemical criteria.
Case of Diabetes1
Nature of sample

Glucose (mg/dl)

Whole Blood

3

Plasma

Venous

Capillary

Venous

Capillary

Fasting

>120

>120

>140

>140

2 hr after glucose load

>180

>200

>200

>200

WHO 1985; Technical Report Series No.727

1CD Codes:



The ICD 9 classifies the Diabetes Mellitus as adult onset type and juvenile onset type. The
corresponding code for Diabetes ICD 9 is 250. The tenth revision introduced a new coding
system which distinguishes between insulin dependent (E10), non insulin dependent (El 1),

malnutrition related diabetes (EI2), other specified (E 13) and unspecified (E14) Diabetes.

o

Gestational diabetes is recorded elsewhere. As per ICD norms if a mention of Diabetes is made in

d

part I of death certificate, it should be considered as the underlying cause.
Natural History
The details of natural history of diabetes and its complications are presented in a tabular

form in next page.

60

5

Preliminary results of Disease Burden -NOT FOR QUOTATION 9 October 1995

>
>

3

Risk Factors

Genetic, Environmental

Parental history
Diet (>fat).
Lifestyles (<Phy.activity)
Obesity

Migrant studies, Studies in
low income urban areas

Incidence

Between 30-69 yrs. there is a
straight line relationship of log
odds of NIDDM to age with a
slope of 0.066 year-1.
Low and high prevalence
populations varies only in
constant terms used in model

Age specific incidence
pattern

Review article of Paul
McKingue

Prevalence

Among adults prevalence rates
increased with age. Prevalence
was less among females

Age and sex specific
prevalence rates

Community based surveys
undertaken in different parts
of India

Remission

Nil_____________________

Treatment

Percent receiving treatment

About 50% of the cases
detected were known cases

Hospital based studies

Complicatio
ns

Specific

>Incidence of blindness
incidence of nephropathy
>Diabetic foot

Follow-up studies. Hospital
based studies

Non specific

>MyocardiaI infarction
>Stroke

Follow-up studies, hospital
based studies

Case fatality

Age and sex specific case
fatality rates

Estimating case fatality on
the basis of known
prevalence and reported
deaths due to diabetes

RR

Influence of increased RR on
age and sex specific
mortality rates

Follow-up studies
undertaken at Fiji

3
3

3

3
3

3
3
3

3
3

Mortality

5

5

5

9
9

3
3
3

i

t

3

£

Source of information

Description

>

3

Out come

Natural
History

61

Az' • >

Preliminary results of Disease Burden -NOT FOR QUOTATION 9 October 1995

Review of studies undertaken in India:

Year

Author

'3

3

Diabetes prevalence studies undertaken in India
Population
Screening
Place

Prevalenc
e (%)
____ 2A
2.3

Patel et al

1959 Bombay

18243 volunteers

Post prandial glycosuria

Ganguly et al

1964 Lucknow

1445 rural hh survey

Post prandial glycosuria

Ahuja et al

1966 Delhi

1027 volunteers

PP glycosuria and bl. glucose

Berry et al

1966 Chandigarh

3846 urban hh survey PP glycosuria

2.9

Satynarayana
Dutta et al
Ahuja et al
Jayarao et al
ICMR

1966 Hyderabad
<\
1968 Pondicherry
19.72 New Delhi
1972 Hyderabad
1972-75 6 urban centres

21396 volunteers
PP glycosuria
2694 urban hh survey PP glycosuria
1639 urban hh survey Post glucose blood sugar
2006 rural hh survey Post prandial glycosuria
19077 hh survey
Post glucose blood sugar

4.1
0.7
2.7

Post glucose blood sugar

1.5
0.9

3.1
2.4

5 rural centres

15177 hh survey

6.2

2.4

2.1

Tripathy et al

1979 Koraput

Patel

1986 Bhadran, Gujarat

2296 tribal volunteers Post glucose boood sugar
3374 rural h h survey Post prandial glycosuria

Verma et al

1986 Delhi

6878 hh survey

Inquiry for known diabetes

Rao et al

1987 Eluru AP

3579 lili survey

Inquiry for known diabetes

Murthy et al

1984 Tenali AP

Urban

4.7

Ramachandran
et al

1992 Madras

Urban
Rural

8.2
2.4

3,8

Several studies have been undertaken in India to know the prevalence of diabetes. The
criteria used to define a case of diabetes varied from verbal enquiry for known diabetes to WHO

suggested case definition for diabetes. Hence, it is difficult to compare the prevalence rates

reported by these studies.
The largest survey covering 34,194 persons above the age of 14 years was undertaken by
the Indian Council of Medical Research (1972-75). The case definition used by the ICMR study is.

those with blood glucose values more than 130 mg/dl in the capillary blood after oral

administration of 50g of glucose. So far this is the largest survey undertaken in the country and
considered to be representative. The other studies demonstrated increasing prevalence with age.

3

Males were more frequently affected with a sex ratio of 1:0.6 or even less among females. The
estimated average duration of disease is about 8.1 years17.

17

PV Rao; Risk factor analysis in diabetes mellitus as related to social progress in Indian Populations 1994
62

3

Preliminary results of Disease Burden -NOT FOR QUOTATION 9 October 1995

Estimation of prevalence and mortality due to diabetes:

Prevalence :

Survey undertaken by Jayarao et al in rural Hyderabad estimated a prevalence of 2.4%

'3

which is higher than the ICMR aggregated rural prevalence. Since Jaya rao’s study is undertaken

in AP and covered 2006 households we have considered it to be representative of rural AP. We

3

have taken the prevalence reported by Jayarao's study as such for rural AP. Even though this is

*3

higher than the ICMR estimates for rural India, a recent study (Ramachandran et al) in rural Tamil .

'3

Nadu suggests that the prevalence in rural areas are around 2.4%. We have assumed that crude

3

prevalence of diabetes among rural males above 14 yrs will be 2.4%. In case of females GBD

3

estimates used the same prevalence as males. However, studies undertaken in India suggest that

3

the prevalence of diabetes among females is lesser than males. Hence we have applied and

O

adjustment factor of 0.75 on the estimated incidence of males get the corresponding values for
the females.

Considering the reported higher prevalence in urban areas we have assumed that both
incidence and prevalence in urban AP are higher than the rural areas. The ICMR survey suggested

that prevalence of diabetes is 1.4 times higher in urban areas. By applying a factor of 1.4 to the

©

reported prevalence of this study we have estimated the prevalence of diabetes in urban AP. This

gave a prevalence of 3.4% which is slightly higher than the ICMR estimates of urban areas but
closer to small scale studies undertaken in urban AP and Madras. We have assumed that urban

males above 14 years will have a crude NIDDM prevalence of 3.4%. Considering reported lower

©

prevalence among females an adjustment factor of 0.75 was applied for the estimated incidence

among males to arrive at the corresponding rates for females.
Mortality:

We have taken the APBD estimated deaths in urban areas for males and females as such.

The CSMR rates are closely comparable with the GBD India estimates. In case of rural areas we
have noticed that in case of males in 60+ age group the SCD estimates gave a cause specific

©
©
©

mortality rate of 4 per thousand which we felt is an over estimate. Hence, we have assumed that
the CSMR in rural males above 60 Ys in rural areas would closer to that of urban areas. Since the

incidence and prevalence in rural areas are lesser than urban areas this assumption gives higher

63

33

.

Preliminary results of Disease Burden -NOT FOR QUOTATION 9 October 1995

case fatality in rural areas which is quite plausible. For other age groups we have used the SCD
estimated death numbers as such which are close to CSMR of urban areas.

*

Estimation of Incidence and Consistency Check:
The above estimates on prevalence, cause specific mortality and remission were used to

estimate the incidence rates and duration of diabetes through DISMOD. Through an iterative

process the incidence and case fatality rates were adjusted to achieve the estimated prevalence and

reported deaths. The results of the outputs from DISMOD are presented in the table.

Estimates of age and sex specific incidence and prevalence of Diabetes from DISMOD
Age group Annual Incidence rate/1000
Annual prevalence rate/1000

j

Rural Male Rural
Urban
Urban
Rural Male Rural
Urban
Urban
I
Female
Male
Female
Female
Male
Female
15-44
0.38 ______ 0.26
0.71 _______ 0.54
5.47 ______3.77
10.44
7.88
7.49
45-59
5.25
13.22
10.22
45.52
64,61
118.43
92.16
60+
11.37 ______ 8.38 _______ UX9
14.19
211.59
154.29
375.14
300,25
Crude rates
1.84
1.39
2.53
2.14
24.11
18.48
34.06
29.95
Estimates of cause specific mortality due to diabetes from DISMOD
Age group Annual Cause specific mortality rate /1000
Annual cause specific deaths
Rural Male Rural
Urban
Urban
Rural Male Rural
Urban
Urban
Female
Male
Female
Female
Male
Female
15-44 ___________ 0.02
0.01
0.02 ______ 0.01
187 ________ 124
76 _________ 54
45-59 ________ 0.31
0.19
o.3l
0.2
952
588
308
193
[60+
___________ 1.84
1.41
I.X
1.4
2374
2863
683
661

Estimation of disability:
The complications of diabetes could be specific affecting eyes, kidneys and feet. These

complications include retinopathy and other changes in eye like cataract, diabetic nephropathy and
neuropathic ulcer in the legs and feet leading to prolonged immobilisation and sometimes

a>

amputation. These complications do not occur in non diabetics. In addition, the non specific
complications of diabetes include the conditions such as increased risk from stroke and ischemic

heart disease. In hospital based studies undertaken in India , 72% of the hospitalised diabetics died
due to vascular complications. Renal disease is an important cause of death1*. The incidence of

major complications due to diabetes increases exponentially with increasing duration of diabetes.

it

P V Rao Risk factor analysis in Diabetes Mellitus as related to social progress in Indian Populations New Delhi 1994
64

3

Preliminary results of Disease Burden -NOT FOR QUOTATION 9 October 1995

1. Blindness:

Follow-up study in Wisconsin USA showed that 4% of diabetic patients develop

blindness19. Another study in UK had estimated the incidence of blindness in diabetics to be
around 5/1000 person years2".

2. Renal Failure:

3

In a cohort study undertaken in Germany the cumulative risk of developing renal failure
requiring transplant was 2% after 15 years of diabetes, 5% after 20 years of diabetes and 10%'

*3

after approximately 25 years of diabetes21.

3. Diabetic foot:
Development of neuropathic ulcers is one of the commonest complications of diabetes

These lesions require prolonged immobilisation and nursing care. In a study undertaken in elderlydiabetic patients in UK the prevalence of foot ulcers was 3%. US national data for 1987 show that

lower extremity amputations for non traumatic conditions is about 8 per 1000 diabetic individuals

4. Diabetes as a risk factor for other diseases:
Estimates of routine US data for diabetes and follow up study undertaken in Chile22

suggest that diabetes is an important risk factor for many diseases.
Diabetes as a risk factor
Disease / complication
Relative Risk
Coronary' bean disease
2-5
Stroke
2-3

6&

Tuberculosis

6

Blindness

20

End Stage Renal disease
Amputation

o



25

______40

The estimates of disability weights are based on all these factors. For the sake of
comparability the same disability weights used for the GBD estimates have been used for APBD

study also.
Moss S E el al: The incidence of vision loss in a diabetic population; Ophthalmology 1988 95; 1340-1348
JO

Dia^r

b
b
b
3

°L

a': A P0PUla,i°n baSed S'Udy Of 'he inCidenCe of complications associated with Type 2 d^t*

uiaoetic Med 1991; 8 928-933

in me elderjy

tti
aftln9 9r0UP’ Prevalence of sma11 vessel and targe vessel disease in diabetic patients from 14 centres. The WHO
muft.nat.onal study of vascular disease in diabetics. Diabetolgia 1985; 28; 615-640
1989; 117-979.983

TUberCUl°S'S 3nd dlabe{es melltlus : a longitudinal retrospective study in a teaching hospital. Rev Med Chil

65

*

i

Media
07949.pdf

Position: 2827 (3 views)